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ABSTRACT 
The bacteriophage T4 regA protein translationally represses over 30 T4 early 
genes, including the regA gene, by binding to the translation initiation region of the T 4 
mRNAs (Karam et al., 1981). Although the recognition sequence has been at least 
partially characterized in a number regA sensitive mRNAs, there is no consensus 
sequence or structural feature that is recognized by regA in all transcripts (Winter et al., 
1987; Webster et al., 1989; Unnithan et al., 1990). Recent studies have identified an 
RNA binding site on regA protein, but there remains a large gap in our understanding of 
how regA protein functions to temporally repress multiple mRNAs (Gordon et aI., 1999). 
A genetic screen was developed to further identify regA protein:RNA interaction 
sites. This approach uses a two-plasmid system in which lacZ expression is placed under 
the translational control of T4 regA via the gene 44 recognition element (gene 44 RE) 
(AAUGAGGAAAUU) on plasmid pLacZ-44RE. For regA expression the regA gene 
was cloned into a pACYC derivative thereby placing expression of regA under the 
control of a strong IPTO inducible promoter. The two plasmids were then transformed 
into the E. coli strain WM1/F'. This approach allowed the rapid selection of regA 
mutants with altered RNA binding affinity using a blue/white selection process. After 
selection, the regA mutants were further characterized by sequencing of the mutant 
genes, as well as by gel mobility shift assays with the mutant proteins and an RNA oligo 
XII 
of the gene 44 RE. Beta-galactosidase assays were also performed to quantify repression 
levels obtained by IPTO induction of regA in cells transformed with the mutant regAs 
In subsequent experiments, the gene 44 RE was mutated at two of the twelve 
bases in order to vary regA affinity for the binding site and thereby vary regA repression 
of the lacZ mRNA translation. In another experiment the Shine-Dalgamo sequence 
upstream of the lacZ gene was weakened to reduce b-galactosidase expression. 
Blue/white assays were performed to determine if these base mutations produced 
variations in color due to variable expression of beta-galactosidase. 
After comparing lacZ expression from plasmids with the various gene 44 RE 
mutants, the regA gene was randomly mutagenized and the blue/white screen was used to 
look for "gain of function" mutants. Potential mutants were expected to be altered in 
their RNA binding specificity. The mutant colonies were sequenced to identify specific 
mutations, in an effort to identify residues that are important in the recognition and 
binding of RNA targets. The effects of individual mutations were further assayed by the 
use of gel mobility shift and ~-galactosidase assays. 
In other experiments color screening assays were performed to compare cells 
expressing T4 regA with cells expressing the regA homologue found in bacteriophage 
RB69. Previous studies had indicated that RB69 regA had a greater affinity for RNA 
than did T4 regA, in vitro. The in vivo color assays were performed to determine if the 
higher affinity in vitro translated into greater repression of lacZ in vivo. Results from 
these screens indicate that the hierarchy of repression of lacZ expression is from plasmids 
with different gene 44 REs is different for T4 regA and RB69 regA proteins. 
Xll1 
The work described in Chapter II of this thesis is concerned with the aryl 
hydrocarbon receptor protein (AHR). Recent studies have shown that the AHR protein is 
rapidly degraded both in vivo and in vitro after exposure to agonist (Pollenz, R.S., 1996; 
Giannone et a/., 1998; Giannone et a/., 1995; Pollenz et al., 1998; Roman et al., 1998; 
Sommer et al., 1998). Additionally, it has been shown that the AHR contains putative 
Nuclear Export Signal (NES) and Nuclear Localization Signal (NLS) sequences 
(Davarinos and Pollenz, 1999; Ikuta et al., 1999; Pollenz and Barbour, 2000). 
The purpose of the studies detailed in this thesis was to generate plasmids which 
express AHR mutant proteins that contain mutant NES or NLS sequences but are 
unimpaired in all other aspects of AHR functionality. These studies have shown that it is 
possible to generate AHR proteins with mutations in the NES that dimerizes with ARNT, 
binds DNA and supports ligand-mediated gene induction. These studies have also shown 
that AHR proteins with mutant NLS sequences are also capable of dimerizing with 
ARNT and binding to DNA. Additionally, these studies have indicated that the NLS 
mutants were degraded more slowly after agonist exposure than wild type AHR 
suggesting another level of regulation of the AHR pathway. 
CHAPTER I 
INTRODUCTION 
A. Protein:RNA Interactions 
Protein:RNA interactions are abundant and crucial for life. Whether beginning 
with transcription of RNA by the protein RNA polymerase or ending with the ribosomal 
translation of proteins from the RNA message, these two types of molecules are 
inseparable. Not only are there protein:RNA interactions at the genesis of either type of 
molecule, but for many RNA molecules, these interactions end only with their 
degradation. Between genesis and degradation of protein and RNA, protein:RNA 
interactions are necessary for a variety of tasks which include mRNA capping, splicing, 
polyadenylation, and tagging the mRNA for export to the cytoplasm (for review see Burd 
and Dreyfuss, 1994). After export to the cytoplasm still other protein:RNA interactions 
are necessary for the regulation of translation or for the protection of the RNA from 
degradation until it has served its purpose. Finally, the eventual degradation of the 
mRNA message is accomplished by still more protein ribonucleases. 
To accomplish the varied tasks, which require protein:RNA interactions, proteins 
have evolved a number of different RNA binding motifs (Burd and Dreyfuss, 1994). 
Many of the motifs have, to a greater or lesser extent, been characterized, and some of the 
better-known of these are: the RNP motif, the arginine-rich motif (ARM), the RGG box, 
and the KH motif. Although these RNA binding motifs have been studied in great detail, 
much work remains to be done. New RNA binding motifs such as the helix-loop-groove, 
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found in the T4 RegA protein, are being discovered (Gordon et al., 2000). Hopefully, 
characterization of these new motifs and others yet to be discovered will offer increased 
insight into the many important cellular processes impacted by protein:RNA interactions. 
B. T4 RegA protein 
The bacteriophage T4 regA gene was discovered in the early 1970s when it was 
observed that the T 4 mutations, sp62 and R9, resulted in the overexpression of T 4 early 
proteins (Wiberg et al., 1973; Karam and Bowles, 1974). These mutations were mapped 
to a region between gene 43 and gene 62 and it was determined by in vitro coupled 
transcription/translation assay that this region encoded a protein that repressed the 
expression of T4 early genes (Winter et al., 1987). This protein was T4 RegA a 
translational repressor protein with a molecular weight of 14.6 kD and a pI of 9.6 (Adari 
et al., 1985). 
T4 RegA protein translationally represses over 30 T4 early genes, including the 
regA gene itself, by binding to the translation initiation region (TIR) of the T4 mRNAs, 
and blocking access of the 30S ribosomal subunit to the TIR (Karam et al., 1981). The 
large number of genes translationally repressed by T4 RegA along with the observation 
that the mRNA binding sites for RegA do not share a highly conserved consensus 
sequence or have similar secondary structures make RegA unique among RNA binding 
proteins discovered so far (Adari et al., 1986). Discovering the means by which RegA 
accomplishes the hierarchical repression of its various targets has the potential for greatly 
increasing our understanding of protein:RNA interactions. 
The crystal structure of T 4 RegA protein revealed that the tertiary structure 
consists of two domains, I and II, which together contain two f3-pleated sheets, 3 u-
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helices, and one tum of a 3/10 helix (Kang et al., 1995). Additionally, it was determined 
that T4 RegA exhibits structural similarity to the snRNP UIA protein, and other RNA 
Binding Domain (RBD)-containing proteins (Kang et al., 1995). However, mutagenesis 
studies revealed that the RBD-like motif in RegA protein does not function in RNA 
binding (Gordon et al., 1999). To better define the region of RegA protein that 
participates in RNA binding, molecular modeling has been used to identify exposed basic 
and aromatic residues that could participate in RNA:protein interactions. Consequently, 
a crevice and cleft region were discovered that were potential RNA binding regions 
(Gordon et aI., 2000). Mutations have been introduced into cloned RegA protein within 
the crevice and cleft regions as well as into exposed amino acid residues, and the effects 
on RNA affinity have been measured by RNA gel shifts. This combined approach of 
molecular modeling and site-directed mutagenesis has recently led to the identification of 
the RNA binding site of the RegA protein and the discovery of a new RNA binding motif 
(Gordon et al., 1999). 
Although the identification of an RNA binding site is of primary importance in 
understanding the role of T4 RegA, many additional questions are as yet unanswered. 
The method by which RegA is able to temporally discriminate in the repression of its 
various targets has yet to be completely understood. Additionally the role of amino acid 
residues outside the primary binding site is as yet unclear. A primary focus of ongoing 
research on T4 RegA is the development of new approaches and tools to aid in answering 
these questions. 
c. RB69 RegA protein 
One of these new tools IS the homologue of T4 RegA found In the 
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phylogenetically related bacteriophage RB69. Recent cloning and nucleotide sequencing 
of RB69 Reg A protein showed that its predicted amino acid sequence is 78% identical to 
that of T4 RegA protein (Joswik and Miller, 1992). However, gel mobility shift assays 
have shown RB69 Reg A to have a 7-8 fold higher affinity for the T4 gene 44 recognition 
element (gene 44 RE) RNA than does the T4 RegA protein itself (Sengupta et al., 2000). 
This observation provides an opportunity for better understanding of structure-function 
relationships in RegA protein. The identification of the region( s) or amino acid( s) of the 
protein responsible for the difference in affinity for gene 44 RE may help explain a great 
deal about the mechanics used by RegA to discriminate between its target sites. 
D. Two-plasmid genetic screen 
As a complementary approach to site-directed mutagenesis, a novel genetic 
system developed by Jain and Belasco was applied to the RegA system. This approach 
uses a two-plasmid assay system to screen for RegA mutants with altered RNA binding 
specificity (Jain and Belasco, 1996). In the Jain and Belasco system the Rev protein 
binding site on Rev genomic RNA, called the Rev Recognition Element (RRE), was 
placed immediately upstream of the lacZ gene to create the plasmid placZ-IIB. In this 
plasmid, the lacZ gene is under the control of a constituitively active promoter and 
therefore does not require induction to produce (3-galactosidase protein. However, the 
fusion of the RRE to lacZ potentially makes expression of lacZ subject to translational 
repression by Rev. The plasmid placZ-liB also carries the gene for resistance to the 
antibiotic ampicillin. In the second plasmid, pREV1, the Rev gene is inserted and placed 
under control of the isopropyl-(3-D-thiogalactoside (IPTG)-inducible lac promoter to 
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create pREVl. The pREVl plasmid also carries the chloramphenicol acetyl transferase 
(CA T) gene for resistance to the antibiotic chloramphenicol. 
The two plasmids placZ-IIB and pREVl were then co-transformed into E. coli 
cells. After transformation with both plasmids the cells were plated on 5-bromo-4-
chloro-3-indolyl-~-D-galactoside (X-Gal) and X-Gal plus IPTG. X-Gal is a colorless 
substrate for the beta-galactosidase enzyme. When X-Gal is cleaved by beta-
galactosidase the resulting product is blue. It was expected that cells containing the 
expression vector placZ-IIB and grown on X-Gal plates, would be blue due to the 
enzymatic activity of beta-galactosidase. Since the RRE is immediately upstream of the 
lacZ gene in placZ-IIB, binding of Rev to the RRE should interfere with ribosome 
binding to the lacZ mRNA and block translation of the lacZ message. It is expected that 
colonies grown on the X -GallIPTG plates will be white since IPTG induction of Rev 
synthesis should inhibit translation of lacZ. Beta-galactosidase assays of these cells 
grown in liquid cultures were also performed to compare lacZ expression in the induced 
and uninduced cells. 
Since Rev protein represses lacZ expression by binding to the RRE and thereby 
blocking the ribosome from binding to the Shine-Dalgamo sequence, point mutations 
were made in the Rev Recognition Element in the placZ-lIB plasmid in order to reduce 
the affinity of Rev for the RRE. These mutations were co-transformed into cells with the 
wild type pREVl plasmid. The cells were then plated on X-gal and X-gaIlIPTG plates 
and screened for loss of ability of Rev to repress beta-galactosidase expression. The 
inability of Rev to repress some of the mutants indicated which individual bases were 
most critical in Rev protein:RNA interactions. 
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Next a mutagenic PCR technique was used to introduce random mutations into 
the rev gene in hopes of creating a mutant or mutants that would regain the ability to 
repress lacZ expression by binding to the defective RRE (Cadwell and Joyce, 1992). 
This technique introduces a mutation for approximately every 1000 base pairs. The 
resulting PCR products were ligated into cut pREY 1 vector to produce a library of 
plasm ids containing mutated rev genes. WMI cells were then transformed with the 
ligation mix and grown in culture overnight. DNA was extracted from the overnight 
culture and stored as a mutant library for use in later experiments to screen for "gain of 
function" mutants. 
WMI cells were co-transformed with the placZ plasmids containing the mutated 
RREs and the mutant rev library. The co-transformants were plated on X-Gal IIPTG 
plates, and grown overnight. The resulting colonies were examined for color variances 
and lighter blue or white colonies were selected as potential "gain of function" mutants. 
The selected colonies were grown in culture overnight and plasmid DNA was extracted. 
The resulting plasmids were sequenced and examined for mutations. A number of "gain 
of function" mutants were identified with this screen. From the location of the mutations 
within the protein, Jain and Belasco were also able to identify the residues most 
important for Rev binding to its RNA target and thereby determine the probable RNA 
binding site of Rev protein. 
II. SPECIFIC AIMS 
Although recent developments have given considerable information about the 
function of RegA protein, much is still unknown. The ability of RegA to temporally 
repress a large number of genes, which do not possess a consensus RNA target, is of 
particular interest. The work presented in this chapter was designed to provide 
information about the function of T 4 RegA protein in this area. In an effort to gain 
insight into RegA's ability to recognize such a variety of RNA targets this project had the 
following specific aims: 
1. To determine if the 12 nucleotide T4 gene 44 recognition element sequence 
confers sensitivity to T 4 RegA repression of the lacZ gene in vivo and, if so, 
does RegA protein exhibit the ability to distinguish between wild type, G-7, 
and G-9 variants of the gene 44 RE in vivo. 
2. To identify mutants ofT4 RegA with altered RNA binding specificity. 
3. To determine if the T4 gene 44 RE confers sensitivity to expression by RB69 
RegA of lacZ in vivo. 
III. MA TERIALS AND METHODS 
Bacteria: 
Escherichia coli (E. coli) WMI/F': This cell line carries the lacZ gene. It also carries the 
recA56 arg-, lac-proXIII nat, rifIF', and lactI genes. 
Epicurian Coli® XLI-Blue (Stratagene): Supercompetent E. coli of strain recAI endAI 
gyrA96 thi-I hsdRI7 supE44 relAI lac [F' proAB lacfIZ~MI5 TnlO (Te{)]. 
Plasmids: 
pASI-regA: This plasmid (also called pKW8) is the pASl expression vector containing a 
560 bp insert with the regA gene. The gene (366 bp) is part of a Bam HIISal I fragment. 
RegA protein expression is inducible by nalidixic acid treatment. 
pASt-RB69 regA: The RB69 regA gene was cloned into the pAS} vector. Like pAS 1-
regA, RegA protein expression is induced by treatment with nalidixic acid. 
pREVl: This plasmid is derived from pACYCI84. It codes for chloramphenicol (cam) 
resistance. This plasmid carries the rev gene under transcriptional control of the lac 
promoter. 
pACYC-WTT4: This plasmid is derived from pREVl. The rev gene was excised from 
pREVI and replaced with T4 regA. 
pACYC-WTRB: This plasmid is derived from pACYC-WTT4. The T4 regA gene was 
excised from pACYC-WTT4 and replaced with RB69 regA. 
pJacZ-IIB: This plasmid is derived from pREVI. The rev gene was excised from 
pREVI and replaced with T4 regA. 
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placZ-44RE: This plasmid is derived from placZ-IIB. The translation initiation region 
was excised from placZ-IIB and replaced with theT4 gene 44 RE. 
placZ-RE2: This plasmid is derived from placZ-44RE. The stem-loop immediately 
upstream of the T4 gene 44 RE was disrupted by site-directed mutagenesis. 
placZ-G-6: This plasmid is derived from placZ-RE2. The guanine at the sixth base 
upstream of the adenine of the start codon was mutated to thymine. 
placZ-G-7: This plasmid is derived from placZ-RE2. The guanine at the seventh base 
upstream of the adenine of the start codon was mutated to thymine. 
placZ-G-9: This plasmid is derived from placZ-RE2. The guanine at the ninth base 
upstream of the adenine of the start codon was mutated to cytosine. 
Buffers 
lOX T4 polynucleotide kinase reaction buffer (USB): 0.5 M Tris-HCI, pH 7.6, 100 
mM MgCI2, 100 mM 2-mercaptoethanol 
lOX mutagenesis buffer (Stratagene): 100 mM Tris-acetate, pH 7.5, 100 mM 
magnesium acetate, 500 mM potassium acetate (KC2H30 2), pH 7.5 
lOX reaction buffer (Stratagene): 100 mM KCl, 60 mM (NH4)2S04, 200 mM Tris-HCl, 
pH 8, 20 mM MgCI2, 1% Triton® X-lOa, 100 mg/ml nuclease-free bovine serum albumin 
(BSA) 
PI resuspension buffer (QIAGEN): 100 f..lg/m1 RNase A, 50 mM Tris-HCI, 10 mM 
EDTA, pH 8 
P2 lysis buffer (QIAGEN): 200 mM NaOH, 1 % SDS 
P3 neutralization buffer (QIAGEN): 3 M potassium acetate (KC2H302), pH 5.5 
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QBT equilibration buffer (QIAGEN): 750 mM NaCI, 50 mM MOPS, pH 7, 150/0 
isopropanol, 0.15% Triton® X-I 00 
QC wash buffer (QIAGEN): 1 M NaCI, 50 mM MOPS, pH 7, 150/0 isopropanol 
QF elution buffer (QIAGEN): 1.25 M NaCI, 50 mM Tris-HCI, pH 8.5, 15% 
isopropanol 
EB buffer (QIAGEN): 10 mM Tris-HCI, pH 8.5 
Freeze/thaw buffer: 20 mM Tris-HCI, pH 7.5, 100 mM NaCI, 1 mM EDTA, pH 8 
Start Buffer (pH 7.4 - 7.6) (Pharmacia Biotech): 20 mM phosphate, 0.5 M NaCI, 10 
mM Imidazole 
20X SSC (pH 7): 3 M NaCI, 0.3 M sodium citrate 
Media 
LB: 0.17 M NaCI, 1 % tryptone, 0.5% yeast extract, pH to 7 with 5 N NaOH 
LB agar plates: 0.17 M NaCI, 1 % tryptone, 0.5% yeast extract, pH to 7 with 5 N NaOH, 
200/0 agar (F or antibiotic selection add appropriate antibiotic) 
IPTG: isopropyl-~-D-thiogalactoside; Fisher 
X-GAL: on 5-bromo-4-chloro-3-indolyl-~-D-galactoside; Fisher 
ONPG: o-nitrophenyl-~-D-galactopyranoside; ACROS 
Site-directed mutagenesis 
All mutagenesis for this project was performed with this Stratagene 
QwikChange™ kit. Mutagenic primers (25-45 bases long) were designed as 
complementary pairs so that a primer would anneal to each strand on the template. The 
desired mutation was situated in the center of the primers. The primers were synthesized 
by MUSC's Biotechnology Resource Laboratory. The lyophilized primers were 
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resuspended in 1 ml 20 mM Tris-HCI, pH 7.5. In thin-walled PCR tubes, IX reaction 
buffer (10 mM KCI, 6 mM (NH4)2S04, 20 mM Tris-HCI, pH 8, 2 mM MgCh, 0.1 % 
Triton® X-I00, 10 mg/ml nuclease-free BSA), 100 ng plasmid template, 125 ng 
mutagenic primers, and 0.20 mM dNTPs were mixed and diluted to a final volume of 50 
J..tl with distilled water. To each mutagenesis reaction, 2.5 units (U) of Pfu DNA 
polymerase was added for the amplification of the plasmid. The samples were then 















After mutagenesis, the parental plasm ids were digested for 1-2 hours at 37°C with 
10 or 20 U of Dpn I restriction enzyme. Dpn I digests only methylated DNA. The 
template DNA was extracted from E. coli cells and methylated by the cells natural 
methylation enzymes. The mutagenized plasmids are PCR amplified copies of the 
template and, therefore unmethylated and, unaffected by the Dpn I enzyme. 
Transformation of calcium chloride-competent E. coli cells 
25 ml LB was inoculated with 0.1 to 0.5 ml of E. coli cells. The culture was 
grown to an optical density (OD) of 0.6 at 590 nm (ODS90). At this point, the culture was 
incubated on ice for 30 minutes. The culture was centrifuged for 15 minutes at 6,000 
rpm. The resulting pellet was resuspended in 10 ml of 100 mM CaCl2 and incubated on 
ice for 20 minutes. The cells were again spun down for 15 minutes at 6,000 rpm. 
Finally, the pellet was resuspended in 2.5 ml 100 mM CaCho The cells were left on ice 
for 0.5-3 hours or were refrigerated overnight. Using chilled pipet tips, 200 JlI of calcium 
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competent E. coli cells were aliquoted into chilled 15 ml conical polypropylene tubes. 
Volumes of mutagenized plasmid, measuring from 2 to 25 JlI, were added to the cells. 
The tubes were gently agitated to mix the cells and DNA, then incubated on ice for 30 
minutes. After this incubation, the cells were heat pulsed at 42°C for 45 seconds and put 
on ice for 2 minutes. Exactly 0.8 ml of pre-warmed (42°C) LB was added to each tube. 
The cells were grown for 1 hour at 37°C (shaking at 220-225 rpm). Aliquots of 100-300 
JlI of transformed cells were spread on 2 LB/amp plates per transformation reaction. The 
plates were incubated, upside-down, at 37°C overnight in an incubator. In the morning, 
clones were picked and used to inoculate 3 ml of LB/amp. These small cultures were 
allowed to grow for several hours at 37°C, then 0.1 ml of cells was used to inoculate 10 to 
25 ml ofLB/amp. The cultures are grown at 37°C overnight. 
Plasmid mini-prep (QIA GEN) 
The cell pellets of overnight bacteria cultures were resuspended in PI buffer (1 ml 
per 10 ml culture), to which 100 Jlg/ml RNase A was added, and transferred to sterile 1.5 
ml sterile microcentrifuge tubes. The cells were then lysed with an equal volume of P2 
buffer. Lysis was done for 5 minutes at room temperature after which the lysis buffer 
was neutralized with P3 buffer (1 ml per 10 ml culture). The lysates were centrifuged, 
and the supernatants were applied to anion exchange columns that had been equilibrated 
with QBT buffer. The columns were washed four times with 1 ml of QC buffer. The 
plasmids were eluted from the columns into sterile 1.5 ml microcentrifuge tubes with 0.8 
ml QF buffer. The plasmids were precipitated with 0.7 volumes (0.56 ml) of isopropanol. 
The samples were centrifuged for 15-30 minutes at 13,000 rpm in the cold. The DNA 
pellets were dried on a Speed Vac (Savant) and resuspended in the appropriate volumes 
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of IX TE. The quality of the prep and yield of the DNA were evaluated by 
electrophoresis on a 1 % agarose gel in IX TAE buffer. The midi-prep and maxi-prep 
protocols were essentially identical to the mini-prep, but scaled accordingly. 
Alternatively Quick-spin mini-preps were used. These prep kits were also from Qiagen 
and the suggested protocol was followed. 
Inductions 
Seed cultures of the cells to be induced were grown overnight at 37DC. In the 
morning, they were used to inoculate a desired volume of LB/amp. The cultures were 
grown at 37°C until they reached an ODS90 of 0.8. One ml of each culture was saved in a 
microcentrifuge tube for electrophoresis later. The remainders of the cultures were 
induced with I mM IPTG and allowed to grow overnight at 37°C. The 1 ml aliquots of 
cells were spun down, resuspended in 100 ~IIX TE buffer, and frozen. In the morning 
the induced cultures were placed on ice, and I ml of the cultures was saved, spun down, 
and resuspended in 100 JlI of 1 X TE. U ninduced and induced cells were electrophoresed 
on a polyacrylamide or polyacrylamide-SDS gel. The proteins were visualized by 
Coomassie blue staining to compare RegA protein amounts in induced and uninduced 
cells. 
eeillysis - freeze/thaw 
Induced cells were harvested by centrifugation. The pellets were quick-frozen in 
a dry ice/ethanol bath for 2 minutes. The pellets were thawed in an ice water bath for 8 
minutes. Freezing and thawing were repeated a minimum of 6 times. After the final 
freeze/thaw, the pellets were resuspended in an appropriate volume of freeze/thaw buffer. 
The cell suspensions were then incubated in an ice water bath for 30 minutes. The 
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lysates were spun down, and the supernatants were taken off the pellets. The pellets were 
resuspended in IX TE. Aliquots of the supernatant and the resuspended cell pellets were 
electrophoresed on a polyacrylamide or polyacrylamide-SDS gel. The proteins were 
visualized by Coomassie blue staining to compare RegA protein amounts in the 
supernatant and in the pellet. 
RNA gel mobility shift assays 
Purified gene 44 RE 16mer RNA (5'-GAAUGAGGAAAUUAUG-3') was 5'-
end-labeled with T4 polynucleotide kinase and y_32p_ATP. Increasing concentrations 
(2.5 nM to 40 nM) of RegA were added to a constant concentration (10 nM) of gene 44. 
Freshly thawed aliquots of induced cell supernatants were used for each experiment and 
discarded. The reactions were carried out in a final volume of 10 III in 10 nM Tris-HCI, 
pH 7.5, 10 nM NaCI, 1 mM EDTA, pH 8, and 1 mM DTT. The samples were incubated 
on ice for 15 minutes then electrophoresed on a 60/0 polyacrylamide gel (NOVEX) in 0.5 
X TBE (89 mM Tris, 89 mM boric acid, 4 mM EDTA, pH 8.3) at 4°C for 1 to 1.5 hours. 
To eliminate the risk of RNase contamination, the electrophoresis apparatus was washed 
thoroughly prior to each use. After electrophoresis, the gel was dried and placed on a 
phosphor storage screen for 1-18 hours. Phosphor imaging on the STORM860 ™ was 
used to quantitate the bound versus unbound 32P_gene 44 RE RNA in order to calculate 
binding constants. 
The apparent association constants (Kapps) were determined by a method similar 
to that of Rebar and Paba (12). The Kapps were calculated by taking three or four points 
on the titration curve. The mean of the binding constants was determined., and the Kapps 
from 2-4 experiments were averaged. In each gel shift assay., wild-type RegA was used 
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as a control. The formula used was: Kapp == [bound RNA]/[free protein] X [free RNA], 
where [bound RNA] == [fraction 32p_RNA bound] X [total RNA]; [free RNA] == [total 
RNA] - [bound RNA]; [free protein] == [total protein] - [bound RNA], assuming that one 
protein per RNA was bound. The gel shifts assays were repeated two to four times, and 
the Kapps were averaged in order to generate a final value. 
Cloning the RB69 regA gene 
The regA insert was amplified by PCR, using Tag DNA polymerase. The primers 
were designed such that a Nde I site was introduced upstream of regA and an existing Sal 
I site downstream of regA was amplified along with the regA gene. 
Clones were visualized by colony hybridization. First, identical grids were 
drawn on UV nitrocellulose filter paper and an LB/amp agar plate. The filter paper was 
placed on another LB/amp agar plate. With a sterile pipette tip or toothpick, bacteria 
colonies were picked from a plate of transformed cells and streaked on the identical grid 
blocks on the nitrocellulose paper and the LB/amp agar plate. The plate with the grid 
master plate and the plate with the filter paper were incubated overnight at 37°C. The 
master plate was then refrigerated. The nitrocellulose membrane, however, was washed 
(i.e. placed on a piece of chromatography paper saturated with the appropriate buffers) 
for 3 minutes in 2% SDS, and 5 minutes each in 0.5 M NaOH/l.5 M NaCI, 1 M Tris/I.5 
M NaCI, and 1 M Tris/l.5 M NaCl. The membrane was then placed (colony side up) on 
dry chromatography paper to dry. The colonies were then UV cross-linked to the 
nitrocellulose membrane. The filter paper was placed (colony side down) on a nylon 
filter in a pan of 2X SSC. They were then rolled up tightly to avoid air bubbles and 
placed into a hybridization tube. Hybridization fluid, pre-warmed to 60°C was added to 
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the tube. The tube was then placed in a rotary oven at 60°C for 30 minutes. 32P-Iabeled 
peR primer was added to the tube and further incubated in the rotary oven for 2 hours. 
The filter was then washed three times in 0.2X SSC/0.1 %SDS, pre-warmed to 60°C. The 
filter paper was then dried on chromatography paper and placed on either X -ray film or a 
phosphor storage screen. Clones that lit up were picked from the master plate. Plasmids 
were purified from the cells and screened by a double restriction digest with BamH I and 
Sal I to see if they released an appropriately sized insert. Potential positives were 
sequenced to confirm they were pAS 1-RB69 regA clones. 
Mutagenic peR: An error prone PCR technique was used to create the regA 
mutant library. The PCR is performed using a reaction mix with a 10 fold excess of 
cytosine and MnCh to encourage incorporation of mismatched base pairs into the PCR 
product. A mutation for every 150-200 base pairs is generated. 
Beta-Galactosidase assays: Cells to be assayed were grown overnight at 37°C. 
After overnight growth the cells were diluted 1-33 in LB containing the appropriate 
antibiotics and grown to an OD600 of approximately 0.5. For the assay 0.5 ml of cell 
culture was diluted with phosphate buffer. The diluted cells were then treated with 1 
drop of 0.1 % SDS and 2 drops of chloroform, vortexed vigorously for 10 seconds, and 
equilibrated in a water bath at 28°C for 5 minutes. Exactly 0.2 ml of ONPG was added 
and the mixture was incubated until a faint yellow color appeared. Na2C03 was then 
added and the OD of the solution was measured at OD420 and OD550. Beta-galactosidase 
was then calculated in Miller Units. 
IV. RESULTS 
Site-directed mutagenesis and subsequent analysis of a large number of 
mutant T4 RegA proteins have revealed the binding site of RegA protein for RNA 
targets (Gordon et af., 1999). Additionally earlier experiments had shown that T4 
RegA protein binding affinity was different for variants of the gene 44 RE in vitro. 
(Webster and Spicer, 1990). However, although these experiments have given a 
great deal of information concern amino acid residues which are important in the 
binding site and binding affinity for RNA targets in vitro, much remains unclear 
concerning the functional activities of T4 RegA. An in vivo comparison of 
repression ability conferred by the differences in binding affinity had not been 
done. Other experiments have shown that the phylogenetically related 
bacteriophage RB69 demonstrates a 7-8 fold higher affinity in vitro for the T4 
gene 44 recognition element (gene 44 RE) RNA than does the T4 RegA protein 
itself (Sengupta et af., 2000). RB69 RegA proteins increased binding affinity in 
vitro for the gene 44 RE also has not been examined for increase repression of 
gene expression in vivo. Finally, although much information has been obtained 
using site-directed mutagenesis, the process is both time consuming and 
expensive. A faster and less costly approach to study T4 RegA protein would be 
of tremendous in the further study ofT4 RegA protein. 
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For the following studies the two-plasmid system, initially developed by 
Jain and Belasco to study the Rev protein, was adapted to screen for T4 RegA 
(Jain and Belasco, 1996). To adapt this system to the study of RegA, expression of 
~-galactosidase was placed under the control of RegA by fusion of the gene 44 RE in 
front of the lacZ gene. RegA was expressed from a second plasmid under the control of 
the isopropyl-~-D-thiogalactoside (IPTG)-inducible lac promoter. Cells containing both 
plasmids were expected to synthesize ~-galactosidase in the absence of regA expression 
(i.e. in media lacking IPTG) and produce blue colonies. Identical cells were expected to 
produce white colonies when regA is expressed (i.e. in media containing IPTG). After 
construction of the gene44 RE-IacZ vector, mutations were introduced in the gene 44 RE 
to reduce RegA protein's affinity for the gene 44 RE site. These gene 44 RE mutations 
were based on the previously discussed in vitro analysis of RegA protein's affinity for 
gene 44 RE variants, and were chosen with the expectation of blocking or reducing 
RegA's ability to repress lacZ expression, thus, resulting in reduced ~-galactosidase 
levels. 
A. In vivo translational repression of a gene44-lacZ fusion gene by T4 RegA protein. 
1. Construction and characterization ofpACYC-regA 
The inducible expression plasmid containing the T 4 regA gene was created by 
replacing the rev gene in pREYl with the T4 regA sequence. In addition to the rev gene, 
this plasmid also contains the gene for chloramphenicol resistance (CAT) which allowed 
for the selection of cells which were transformed with this vector. As a first step in the 
cloning procedure, the rev gene was excised from pREY 1. As shown in Figure l, Cia I 
and N de I restriction sites are located just downstream from the 5' end of the rev gene 
IREV 
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Figure 1: Cloning of regA gene into pACYC expression vector: The plasmid pACYC-
regA was constructed by PCR amplification of the regA gene from pAS l-regA and 
subsequent ligation into pREY 1. The PCR product and plasmid pREY 1 were both 
restriction digested with N de I and Sal I to create sticky ends and to remove the rev gene 
from pREVl. The cut plasmid and PCR product were then ligated with T4 liga.se and 
transformed into CaCl2 competent WMI/F' cells. 
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and a Sal I site is located just downstream of the 3' end of the rev sequence. Since CIa I 
was the more 5' of the two sites with respect to the rev gene, a CIa I I Sal I digest was 
initially chosen to excise the rev gene and linearize pREY 1. 
Initial restriction digests of pREY 1 were performed with CIa I, Sal I, and CIa IISal 
1. Sal I linearized the plasmid but CIa I did not cut. After further study it was found that 
CIa I is sensitive to DNA methylation, and therefore was not a suitable enzyme for use in 
this experiment. Accordingly the restriction digests were repeated using Nde I instead of 
CIa 1. Nde I and Sal I linearized pREVl in both individual digests and in the double 
digest. The use of the N de I restriction enzyme left 18 bases from the rev gene at the 5' 
end of the new coding sequence when T4 regA was inserted into the plasmid. These 18 
bases when transcribed and translated would result in a fusion protein of T 4 RegA with 
six additional N -terminal amino acid residues. 
The T4 regA gene, to be cloned into the pREVl vector, was amplified from the 
plasmid pAS l-regA by PCR. Complementary primers were used which contained an 
Nde I restriction site to be added to the 5' end of the regA coding sequence and 
encompassed a pre-existing Sal I site downstream of the 3' end of the regA gene. After 
digestion with restriction enzymes N de I and Sal I, the resulting fragment was ligated 
overnight into the pREVl vector from which the rev gene had been excised. WMI cells 
were transformed with the ligation mix and plated on Luria Broth (LB) plates containing 
chloramphenicol (cam) to select for cells which had received the ligated vector. The 
plates were incubated overnight at 37°C and examined for colonies the following day. 
The initial attempt at transformation failed to yield clones with the regA insert. 
Analysis of the PCR product showed that they were not completely cut by the restriction 
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enzymes. However, even with partial cutting some of the PCR product should have been 
competent for ligation into the vector. Therefore, the ligation reaction was repeated a 
second time, but again, no transformants containing regA were found. Based on this 
information it was presumed that the concentration of regA insert was too low and most 
of the transformants contained the original pREY 1 plasmid. 
Therefore, to screen for a colony containing regA, a faster and more economical 
method of identifying correct transformants was needed. Accordingly colony filter 
hybridization was used as it is potentially a more efficient selection tool for finding low 
frequency transformants containing the T4 regA gene in the presence of numerous 
pREVl transformants. Accordingly, WMI cells were re-transformed with aliquots of a 
regA-pREVl ligation mix and plated onto six LB/cam plates along with a control 
transformation of wild type pREY 1 plasmid. After overnight growth, there were fifty to 
eighty colonies per plate. These colonies were lifted onto nitrocellulose filter paper and 
probed with a 32p labeled regA DNA fragment produced from the same type of PCR 
reaction use to prepare the T 4 regA insert for cloning. After hybridization overnight, the 
filters were washed, dried and placed on a phosphor image screen for several hours. The 
phosphor screen was then scanned and the developed image was printed onto a 
transparency that was used as a template for locating potential transformant colonies on 
the agar plates. 
Approximately forty colonies were 'identified as potential candidates for 
containing the regA gene. From these, twenty colonies were selected and grown in 
culture overnight. Plasmid DNA was extracted from each of these cultures and 
restriction digests were performed to check for the release of a regA fragment. Aliquots 
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of each digest were examined on a 1 % agarose gel for the release of a N de IISal I 
fragment. Digestion of one of the clones produced a fragment of just over four hundred 
base pairs which was the expected size. This plasmid was sequenced and found to 
contain the T4 regA gene. However, the regA gene contained a single nucleotide deletion 
of a thymine in the second codon. Two of the other potential positive clones were 
sequenced even though there was no fragment in the restriction digest. As expected, 
these clones were negative for the regA gene. 
Although the one positive clone was found to have a mutation, the hybridization 
reaction yielded the first positive regA cloning results to this point. It was decided to 
repeat the hybridization using a faster protocol that did not require overnight incubation. 
This rapid hybridization method was designed to allow for a more accurate selection 
process by making the probed colonies larger and more evenly spaced on the plates. In 
this method WM 1 cells were transformed with the ligation mix and grown overnight as 
before; however, the following day individual colonies were selected and streaked onto 
duplicate plates containing one hundred numbered squares in a grid. On the first plate the 
grid markings and streaks were on a nitrocellulose filter placed onto the agar. On the 
duplicate plate the grid was marked on the bottom of the plate and the streaks were made 
directly onto the agar. The two plates were incubated at 37°C overnight. The 
hybridization reaction was performed on the colonies growing on the nitrocellulose filter 
the following day. This procedure required. the same amount of time as a normal 
hybridization for the first filter or set of filters because of the second overnight growth 
required. However, transformation plates can be stored in the refrigerator and additional 
colonies from the sanle plates can be selected if additional hybridization reactions are 
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necessary. 
After the hybridization reaction the filter was dried and placed on X-ray film 
overnight. The film was developed, and the hybridization filter was placed on a phosphor 
image screen as in the previous screens. For this experiment, the screen was exposed for 
six hours, and then scanned on a Molecular Dynamics phosphor imager. 
This procedure was repeated twice with the ligation mix transformed into WM 1 
cells. The second and third hybridization reactions yielded five and four potentially 
positive clones respectively. Each of these nine clones were selected and grown 
overnight in a 15 ml culture, and plasmid DNA was extracted the following day. Three 
of the nine clones contained the regA sequence, but each of the three contained 
mutations. Two of the clones contained the same mutation of isoleucine 84 to threonine. 
The third positive clone contained an adenine deletion in the fourteenth codon. 
Although there had been some success in obtaining clones containing the regA 
gene, the frequency of clones with mutations suggested that it was necessary to increase 
the number of potential positive clones being found in order to obtain a wild type regA 
clone. To increase transformation efficiency XL I-Blue supercompetent cells were used 
in a new transformation with the pREVIlregA ligation mix. As expected, these cells 
produced a much larger number of transform ants. 
A fourth hybridization was performed which tested 300 (3 plates of 100) colonies 
from the XL I-Blue transformation. Of the 300 colonies tested 46 were indicated as 
potential positives for regA in situ hybridization assay. Ten of the positive clones were 
picked for plasmid preps and sequencing. Four of the selected clones did not contain 
regA. Two contained partial sequences, and two contained single base deletions: one 
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contained a lysine 109 to glycine mutation, and one contained the complete and 
unmutated regA sequence. The clone with the correct sequence was clone # 1 00 from 
plate #3. This plasmid was initially labeled pACYC-regA-3-1 00, and, subsequently, the 
name was shortened to pACYC-regA. 
The above results indicated that there was a recurrent problem with mutations in 
regA, which occurred either during the PCR reaction, which generated the DNA for 
cloning, or in selection during the growth of the transformed cells. Since the majority of 
clones contained mutations, it seemed likely that there was a selection against cells that 
contained a complete and unmutated regA insert. Since high levels of RegA protein are 
known to be toxic to cells, and since the lac promoter had been shown to allow a low 
amount of expression even in uninduced cells (i.e. to allow leaky expression), it is likely 
that the maj ority of WM 1 cells initially transformed with the regA gene were killed by 
the toxic effects ofT4 RegA. 
Because of these effects of RegA on cell viability, a different bacterial strain was 
needed as a host for the vector expressing regA. WMI/F' cells, which contain the lac Iq 
gene which encodes a super repressor of the lac promoter, were selected as a potentially 
better host. The presence of lac Iq was expected to reduce "leaky" expression from the 
lac promoter that occurs prior to induction with IPTG. 
WMI/F' cells were transfonned with pACYC-regA vector DNA from the original 
pACYC-regA-3-100 plasmid prep. After the transformants were plated and allowed to 
grow overnight 3 colonies were selected and grown in culture for plasmid DNA 
extraction. Culture #1 was also grown and induced with 1 mM IPTG at OD .85 and 
allowed to grow overnight. Colonies #2 and 3 were selected and saved as back-ups 
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should colony # 1 contain a mutation. 
After growing overnight, the induced culture (3 -1 00 # 1) was centrifuged to pellet 
the cells for analysis of regA expression. Samples of the uninduced and induced cells, 
and the lysed pellet and supernatant were examined by SDS-PAGE. This analysis was 
performed to confirm that the protein was induced and to examine the solubility of RegA 
after the freeze-thaw lysis. SDS-PAGE analysis indicated that expression of the T4 regA 
gene was strongly induced by IPTG, but the amount of RegA protein in the supernatant 
seemed to be low in comparison with RegA induced from the plasmid pAS 1-regA, the 
plasmid originally used to clone the regA gene. 
To determine if the RegA protein produced by pACYC-~egA was functional, 
RNA gel mobility shift assays were performed on cell supernatants. Clone pACYC-regA 
3-100 # 1 cell supernatant was incubated with a 32p labeled 16 mer RNA oligonucleotide 
corresponding to the T4 gene 44 recognition element and complexes were 
electrophoresed on a native polyacrylamide gel (See Figure 2). The protein produced in 
clone 3-100 appeared to be fully functional, as RNA mobility was retarded even with low 
supernatant concentrations. 
Plasmid DNA from clones #2 and #3 were sequenced to reconfirm the expressed 
RegA protein was complete and without mutations. Sequence #2 was only a partial regA 
sequence but #3 was found to contain the full and unmutated coding sequence for T 4 
regA. It seemed likely that the mutation in clone #2 occurred or was selected for during 
the overnight growth in the WM1 cells used for the original plasmid prep (i.e., before 
transfer into WM1/F' (lacfl) cells). The presence of this mutation after only one 
overnight growth in WM1 cells also served to confirm the necessity of using WMI/F' 
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Figure 2: RNA Gel Mobility Shift Assay of T4 RegA Produced in pACYC-regA. 
The supernatant produced by the freeze-thaw lysis of IPTG induced WM1/F' /pACYC-
regA-3-100 cells was incubated with a 32p labeled 16 mer RNA oligo containing the gene 
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Figure 3: Schematic Diagrams of plasmids placZ-IIB and placZ-44RE: The 
plasmid placZ-IIB was converted to placZ-44RE by QwikChange™ site-directed 
mutagenesis. Eleven bases in the lacZ TIR were replaced with the gene 44 RE in one 
mutagenesis reaction. Excised and inserted DNA sequences are shown in boxes. 
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The QwikChange™ mutagenesis transformation produced approximately 300 colonies 
per plate. One hundred of the colonies were streaked onto a nitrocellulose filter and a 
duplicate LB/ampicillin (amp) plate for hybridization screening. A 32p labeled oligo 
containing the gene 44 RE sequence, AATGAGGAAA TT A, was used as a hybridization 
probe. Six of the colonies gave a positive signal. The six colonies were selected and 
grown overnight for extraction of plasmid DNA. The plasmid DNA was then sequenced 
and examined for the mutation and the proper lacZ sequence. One of the five sequencing 
reactions failed but the other 5 sequences all contained the desired mutation. Three of 
these sequences had additional mutations in the lacZ gene but the remaining two plasmid 
sequences were correct. These two DNAs were saved and labeled placZ-44RE-76 and 
placZ-44RE-65. PlacZ-44RE-76 was selected arbitrarily for use in this study and was 
designated as placZ-44RE. WMl/F' /placZ-44RE cells were grown overnight on X-GAL 
plates. The cells produced blue colonies confirming the presence of a functional lacZ 
gene. 
In order to carry out a successful screen for "gain of function" mutants it was necessary 
to be able to easily distinguish, by color differences, between cells in which functional 
RegA protein is induced and those in which it is uninduced or non-functional. To test 
this ability, WMI/F' cells were transformed with the following combinations of 
plasmids: placZ-IIB/pREVl, placZ-IIB/pACYC-regA, placZ-44RE/pREVl, and placZ-
44RE/pACYC-regA. After plating and overnight growth, individual transformants were 
streaked onto LB/Amp/Cam plates containing X-Gal or X-Gal/IPTG. The appearance of 
cells transformed with the various combinations of vectors is summarized in Table 1. 
As shown in Table I, WMl/F' /placZ-44RE/pACYC-regA cells plated on the X-Gal/IPTG 
30 
PLATES X-GAL X-GAL/IPTG 
PLASMIDS COLOR GROWTH COLOR GROWTH 
PlacZ-IIB ***** White + Blue + 
PlacZ-44RE ***** Blue + Blue + 
PlacZ-IIB pREVl Blue + White + 
PlacZ-IIB pACYC-regA Blue + Blue + 
PlacZ-44RE pREVl B/WMix + B/WMix + 
PlacZ-44RE pACYC-regA B/W Mix + Blue -
Table 1: Color Comparison of WM1/F' Cells Containing Various Different Plasmid 
Combinations on X-GAL and X-GAL/IPTG Plates. In cells transformed with the 
parent plasmids placZ-IIB and pREVl, uninduced (X-GAL) cells are blue while induced 
cells (X-GAL/IPTG) are white. In cells transformed with both placZ-44RE and pACYC-
regA, induction with IPTG inhibited cell growth. Growth and color were unaffected in 
cells transformed with placZ-IIB/pACYC-regA or placZ-44RE. 
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plates gave a mixture of both blue and white colonies. The same cells plated on X-Gal 
plates also produced a mix of blue and white colonies. However, the growth of the 
colonies varied on X-Gal versus X-GaI/IPTG plates. The placZ-44RE/pACYC-regA 
colonies, which were blue, remained blue while those that were white on the X -Gal plates 
showed little or no growth on the X -GallIPTG plates. These results were unexpected, so 
additional streak plates of individual isolates ofWMllF'/placZ-44RE/pACYC-regA were 
made to further characterize the effects of RegA in IPTG-induced and -uninduced cells. 
As before, the individual colonies streaked on the plates did not have homogeneous 
appearance, but rather, were a mix of phenotypes that were eventually categorized into 
three general groups: I) colonies that were blue on both the induced and uninduced plates, 
II) colonies that were blue on uninduced plates and white on induced plates, and III) 
colonies that were white on uninduced plates and had reduced or no growth on induced 
plates. The plates in Figure 4 illustrate all three of the different types of colonies. 
DNA sequence analysis of pACYC-regA plasmids extracted from Type I cells 
revealed that most of the plasmids contained early truncations of the regA sequence or 
deletions of the entire regA gene. DNA sequence analysis of pACYC-regA plasmids 
extracted from Type II cells indicated the plasmids usually contained mutations in a 
single codon of the regA gene or late truncations of the T4 sequence. Gel mobility shift 
assays of the supernatants from freeze-thawed protein extracts of Type II cells produced 
no detectable RNA shift, suggesting the extracts did not contain functional RegA protein. 
However, these cells were blue when plated on X-Gal plates and white on X-Gal/IPTG 
plates. This color change between induced and uninduced cells suggests that RegA was 
active in repressing ~-galactosidase expression. However, since the gel shift was 
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X-Gal Plate X-Ga1fIPTG Plate 
Figure 4: Effects of IPTG induction of RegA on lacZ expression. Both the color and 
growth of bacteria are affected by regA expression in WMI/F IplacZ-44RE/pACYC-
regA. The streaks in grids 2, 6, and 8 are examples of Type I transfonnants that are blue 
on both X-GAL and X-GAL/IPTG plates. The streaks in grids 1 and 5 are examples of 
Type II transfonnants that are blue on X-GAL plates and white on X-GAL/IPTG plates. 
The streaks in ·grids 3, 4, and 7 are examples of Type III transfonnants that are white on 
X-GAL plates and are unable to grow when induced on X-GAL/IPTG plates. 
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negative, the RNA affinity of RegA in these mutants must be significantly reduced. In 
IPTG inductions of RegA in Type II cells, the RegA protein was highly over expressed. 
Presumably it is this ability to be highly expressed without being toxic to the cells that 
allows these low affinity mutants to repress lacZ expression. One example of a double 
mutant was found in Type II cells. This mutant had Gly23Arg and Glu68Gly mutations. 
In gel shift analysis of this mutant there was no detectable retardation of the RNA. 
DNA sequences of pACYC-regA plasmids extracted from Type III cells usually 
contained the unmutated and complete regA sequence, although a few plasmids from 
white colonies were found that did not sequence. These latter cells most probably 
contained a functional regA gene, but were modified in the sequence that is normally 
complimentary to the sequencing primer. These cells were discarded as they were not 
useful for this proj ect. 
The continuing mutagenic tendencies of the regA gene even when transformed 
into cells with the lac Iq genotype necessitated some modification to the protocol used to 
screen for RegA mutants with altered binding specificities. Even though there was little 
color change in induced or uninduced WMl/F' /placZ-44RE/pACYC-regA cells, a color 
difference was found between WMl/F'/placZ-44RE/pACYC-regA cells and 
WM I/F' /placZ-44RE cells lacking pACYC-regA even when both cell types are 
uninduced. Presumably the color difference was a result of leaky expression of regA, 
indicating that induction by IPTG may not be required to differentiate between cells 
expressing RegA proteins with varying affinities for the gene 44 RE. This color 
difference suggests that it is possible to differentiate between cells containing a functional 
T4 regA gene and those containing a non-functional gene, by plating them on plates 
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containing only X-GAL and inspecting the colonies for variations in color development. 
To determine if ~-galactosidase levels of cells grown in liquid culture could be 
correlated with the color variations observed in cells grown on X-GAL plates, ~­
galactosidase levels were measured for WMI/F' cells transformed with the following 
plasmids: placZ-IIB, placZ-IIB/pREVl, placZ-IIB/pACYC-regA, placZ-44RE, placZ-
44RE/pREVl, and placZ-44RE/pACYC-regA. These assays were repeated numerous 
times and, although the actual repression ratios varied, it was possible to determine an 
overall hierarchy of ~-galactosidase repression achieved by RegA and Rev proteins in 
cells containing the various lacZ plasmids. PlacZ-Il/pREVI > placZ-44RE/pACYC-regA 
> placZ-44RE/pREVI > placZ-IIB/pACYC-regA. These results confirmed that regA 
does block the translation of the lacZ gene from placZ-44RE, and coupled with the color 
differences between cells containing functional and non-functional RegA protein, noted 
on X-Gal only plates, suggested that a rapid screen for "gain of function" mutants could 
be developed. 
b. placZ-RE2 
Although the screen for "gain of function" mutants appeared to be possible based 
on the data from experiments with placZ-44RE, the level of repression of lacZ by RegA 
was not as high as expected. Since T4 RegA binds to single stranded RNA targets it 
appeared possible that the stem-loop structure of the original Rev RE located 
immediately upstream of the gene 44 RE could be hindering the binding of RegA. 
Accordingly site-directed mutagenesis was used to modify the 5' untranslated region of 
the RNA to disrupt the large stem-loop structure on placZ-44RE (Figure 5). 
Three bases in the stem structure were mutated from AGG to CAT USIng the 
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QwikChange ™ protocol. This mutation was expected to eliminate the first stem of the 
hairpin structure, producing a smaller stem-loop, which would be farther upstream from 
the gene 44 RE, as shown in Figure 5. It was also hoped that the increased access of 
RegA to the RE would increase the fraction of RegA protein in the cell that is bound to 
the plasmid, and thereby, decrease the overall toxicity of RegA. 
Following mutagenesis and transformation ofWM1/F' cells, six potential mutants 
were selected and sequenced to determine if the mutagenesis reaction was successful. All 
of the selected clones contained the mutated sequence. The altered plasmid was named 
placZ-RE2. 
To determine if a color difference could be observed between IPTG-induced and 
uninduced WM1/F'/placZ-RE2/pACYC-regA cells, sixteen transformed colonies were 
selected and streaked onto X-Gal and X-GaI/IPTG replica plates. After incubation at 
37°C the colonies on the X-Gal plate were blue as expected, but there was little to no 
growth on the X-Gal/IPTG plate. The inhibition of growth on the X-Gal/IPTG plates 
suggest that the toxicity of RegA was not alleviated by the disruption of the stem-loop 
structure in p lacZ-RE2 
To compare the level of RegA repression of lacZ achieved when ~-galactosidase 
is expressed from placZ-RE2 with repression observed from placZ-IIB and placZ-44RE, 
~-galactosidase assays were again performed with liquid cultures. These results 
demonstrated higher repression ratios (r) for cells transformed with placZ-RE2, (r=4-5) 
than those measured for cells containing placZ-44RE (r= 1.5-2). However, these ratios 
were still lower than that observed for placZ-lIB by Rev protein. The results are 
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Figure 5: Schematic diagram of plasmids placZ-44RE and placZ-RE2. 
PlacZ-RE2 was made by site-directed mutagenesis of placZ-44RE to disrupt the 
stem-loop structure of the RRE. This mutation was made to reduce the possibility of the 
stem-loop structure interfering with the binding of T4 RegA to the gene 44 RE. Part of 
the stem-loop remains intact but is moved further upstream from the gene 44 and should 
not interfere with RegA binding. 
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by the proximity of the stem-loop structure of the RRE. It was also determined that 
unrepressed B-galactosidase levels in cells containing placZ-RE2 were 8 to 10 fold 
higher than in cells containing placZ-44RE. This suggests that the stem loop structure in 
placZ-44RE also interferes with the binding of ribosomes to the translation initiation 
region of the gene 44 RE-IacZ fusion gene. 
To determine what level of regA expression produces toxic effects in cells 
containing placZ-RE2, the growth rates of cells induced with varying concentrations of 
IPTG were measured. In these experiments cultures of WMl/F' /placZ-RE2/pACYC-
regA cells were grown to a density of 0.3 to 0.5 OD/ml and then IPTG was added. Two 
separate experiments were performed in which a low range (5-20 mM) and a high range 
(10-100 mM) of IPTG concentration were examined. WMl/F'/placZ-RE2 cells without 
the pACYC-regA plasmid were also assayed at 100 JlM IPTG. As shown in Figure 6, the 
growth of WM l/F' IplacZ-RE2 cells was dramatically reduced by the presence of the 
pACYC-regA vector even in the absence of IPTG induction. It was also apparent that as 
IPTG concentration increased, growth rate decreased. Thus, the growth rate of the cells 
was inversely proportional to the IPTG concentration. This confirmed that RegA 
expression from the low copy pACYC-RegA vector is toxic to the cells, and suggests that 
only low levels of regA expression should be used in screening for RegA mutants. 
In order to determine if there was a level of RegA induction that was permissive 
for cell growth on agar plates, which would allow detection of a color change between 
colonies grown on X-Gal versus X-GallIPTG, streak plates were made on agar containing 
varying concentrations of IPTG. Sixteen colonies of WMl/F' /placZ-RE2/pACYC-regA 
were streaked on X-Gal plates containing 0, 10, 100, and 1000 JlM IPTG. The growth of 
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Figure 6: Growth curve of IPTG induced cells: WMl/F' /placZ-RE2/pACYC-regA 
cells were induced with progressively higher concentrations of IPTG. WMl/F'/pACYC-
RE2 cells were also grown in 100 J..lM IPTG as a control. Growth of cells was found to 
be inversely proportional to IPTG concentration. 
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all sixteen clones decreased as the IPTG concentration increased. However, there was no 
corresponding color change between cells grown at the different IPTG levels. In an 
attempt to avoid the problems of reduced cell growth in the presence of IPTG, the same 
experiment was repeated on X-GAL plates containing IPTG concentrations of 0, 5, 10, 
15, and 20 JlM. Cultures of WMI/pREVI/placZ-IIB, WMI/pACYC-regA/placZ-IIB, 
WMI/pREVI/placZ-RE2, and WM1/pACYC-regA/placZ-44REwere streaked on these 
plates. As shown in Figure 7 there was no color change in any of the cells as the IPTG 
concentration increased from ° to 20 mM IPTG. A possible explanation for the lack of a 
color change on agar plates is that in ~-galactosidase assays of cells grown in liquid 
cultures, lacZ expression was found to be 8-10 fold higher in cells containing placZ-RE2 
than in cells containing placZ-44RE. Because of this increase in expression, it is possible 
that ~-galactosidase levels remain high enough to produce blue colonies on X-gal/IPTG 
plates even in the presence of IPTG induced RegA protein. This possibility suggests that 
placZ-RE2 could potentially be used in a screen for super repressors, since an increase in 
binding affinity could result in repression levels high enough to overcome the high levels 
of lacZ expression from placZ-RE2 and produce white colonies on X-Gal plates. 
c. placZ-G-6, placZ-G-7, and placZ-G-9 
Previous studies of RegA protein binding to synthetic RNAs corresponding to the 
gene 44 RE demonstrated that mutation of some bases in the gene 44 RE reduced RegA's 
binding affinity for the gene 44 RE significantly, while other substitutions had little or no 
effect, as shown the graph in Figure 8A (Webster and Spicer, 1990). In particular, the 
single guanine to cytosine mutation at position G-9 (numbered with respect to the AUG 
start codon) reduced RegA's affinity for gene 44 RE RNA to that of non-specific RNA 
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Figure 7: Streak plates of WMl/F'/placZ-RE2/pACYC-regA cells with varying 
IPTG concentrations. There was no significant color change in cells grown on X-GAL 
plates as IPTG concentration increases. Grids 1-17 contain streaks ofWMl/pACYC-
regA/placZ-RE2 cells. Grids 18-21 contain streaks of WMl/pREVl/placZ-RE2 cells. 




binding. To see if these mutations had the same effects on RegA activity in vivo, three 
plasmids containing mutations in the gene 44 RE on placZ-RE2 were created (see Figure 
SB). These mutants were chosen because they were expected to produce different effects 
on the binding affinity of RegA to the RE. The G-6 substitution was expected to weaken 
the Shine-Dalgarno site of the RE with little effect on RegA binding. It was expected 
that ribosomes would have less affinity for this site and RegA would therefore be able to 
repress lacZ expression from this plasmid more efficiently. The G-7 substitution was 
also expected to weaken the Shine-Dalgarno site but also reduced RegA' s affinity for the 
RE by an order of magnitude, from approximately 107 to 106 M- 1• The previously 
mentioned G-9 mutation was expected to reduce RegA's affinity for the RE to the level 
of non-specific binding, and therefore, RegA should be unable to repress lacZ expression 
from plasmids with this sequence as the target site. The mutation at G-7 was also 
expected to reduce affinity for the gene 44 RE, but to a lesser extent than the G-9 
mutation. The mutation at G-6 was made to weaken the Shine-Dalgarno site of the RE 
without appreciably reducing RegA affinity for the gene 44 RE. 
The placZ-G-6, G-7, and G-9 mutants were introduced into placZ-RE2 using the 
QwikChange 1M site-directed mutagenesis protocol. After mutagenesis and sequencing to 
confirm the mutations, cells containing plasmids placZ-RE2, placZ-G-6, placZ-G-7, and 
placZ-G-9 were plated on X-Gal plates to compare the level of ~-galactosidase expressed 
from the various plasmids. As shown in Figure 9, color development due to ~­
galactosidase activity was highest in cells containing placZ-RE2. Color intensity 
decreased in cells with mutant plasmids in the following order, placZ-G-7, placZ-G-9, 
and placZ-G-6. Based on these results it was concluded that plasmid G-6 did not produce 
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PLASMIDS 
SEQUENCE VARIATIONS X-GAL X-GAL IPTG 
placZ-IIB/pREVl TACAGGATTCAGACAACAAGATG BLUE BLUE 
placZ-44RE/pREGA TACAGGAT~AATGAGGAAATT~TG BLUE WHITE 
placZ-44RE2/pREGA TA~TTGAATGAGGAAATTATG BLUE WHITE 
placZ-44RE2G-6/pREGA TACCATATTGAATGA~TTATG BLUE WHITE 
placZ-44RE2G-7/pREGA TACCATATTGAATG~AAATTATG BLUE LT.BLUE 
placZ-44RE2G-9/pREGA TACCATATTGAA~GGAAATTATG BLUE BLUE 
Figure 8: (A) Effects of base substitutions in gene 44 on affinity of RegA protein 
for gene 44 Recognition Element RNA in vitro. The G to C substitution at - 9 reduced 
affinity to the non-specific level, while some other substitutions reduced affinity by an 
order of magnitude (Webster and Spicer, 1990). (B) Variations of the gene 44RE on 




Figure 9: Color development in cells transformed with placZ-RE2 and placZ-RE2 
variants. Cells co-transformed with each of the placZ vectors were plated on LB/amp 
plates with X-GAL. Cells containing placZ-RE2 show the darkest color while there is 
little or no color in cells containing placZ-G-6. Cells containing placZ-G-7 and placZ-G-
9show similar color development but as a rule color intensity is as follows: RE2>G-7>G-
9>G-6. (Note: These cells do not contain pACYC-regA) 
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enough B-galactosidase to be useful in an assay of RegA repression activity. 
3. In vivo assay of RegA repression of gene 44 RE-lacZ fusion gene. 
Beta-galactosidase assays were performed to determine if RegA protein's 
differences in binding affinity in vitro for variant gene 44 RE binding targets coordinated 
with RegA' s ability to repress gene expression from plasmids carrying the lacZ gene 
fused to the different gene 44 RE variants. Cells containing placZ-RE2, placZ-G-7, and 
placZ-G-9 were assayed along with cells containing placZ-lIB, which doesn't contain a 
binding site for RegA, and cells containing placZ-44RE, which contains a stem loop 
structure which interferes with RegA binding to the gene 44 RE. Cells containing each of 
these plasmids were transformed with each of the plasmids, pREY!, pACYC-WTT4, and 
pACYC-WTRB. Beta-galactosidase was assayed as described in the Materials and 
Methods chapter. As shown in Table 2, B-galactosidase was most highly repressed in 
cells containing the wild type gene 44 RE. Repression was reduced as expected from 
plasmids containing each of the other targets. 
B. Development of a screen for RegA mutants with altered RNA binding specificity 
To further determine if placZ-G-7 and placZ-G-9 were suitable for use in the 
assay of RegA activity, cells containing each of these vectors were transformed with 
pACYC-regA and plated on X-Gal and X-GaIlIPTG plates. Beta-galactosidase 
expression levels appeared to be greatly reduced in cells containing placZ-G-9 and 
pACYC-regA even without IPTG induction, therefore it was decided that the placZ-G-9 
target would not be suitable for the blue-white screen. Cells containing placZ-G-7 and 
pACYC-regA retained enough color that it was considered probable that these cells could 
be used in the blue-white screen. Based on previous results of in vitro binding assays 
which indicated that RegA did not efficiently bind to the G-9 target it was expected that 
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Beta-Galactosidase Assays 
4/22/00 4/27/00 5/23/00 
Miller Repression Miller Repression Miller Repression 
Cell Type Units Ratio Units Ratio Units Ratio 
placZ-IIB 100 mM IPTG 366 *** 443 *** 403 *** 
placZ-44RE 100 mM IPTG 177 *** 74 *** 172 *** 
placZ-RE2 100 mM IPTG 1439 *** 812 *** 1227 *** 
placZ-G-7 100 mM IPTG 137 *** 113 *** 327 *** 
placZ-G-9 100 mM IPTG 108 *** 59 *** 199 *** 
placZ-IIB/pREV 1 100 mM IPTG 392 0.9 66 6.7 679 0.6 
placZ-44RE/pREVI 100 mM IPTG 247 0.7 79 0.9 210 0.8 
placZ-RE2/pREVl 100 mM IPTG 442 3.3 624 1.3 1668 1.0 
placZ-G-7/pREV 1 100 mM IPTG 294 0.5 141 0.8 338 1.0 
placZ-G-9/pREV 1 100 mM IPTG 284 0.4 195 0.3 195 1.1 
placZ-IIB/pACYC-WTT4 100 mM IPTG 323 1.1 396 1.1 671 0.6 
placZ-44RE/pACYC-WTT4 100 mM IPTG 279 0.6 155 0.5 287 0.6 
placZ-RE2/pACYC-WTT4 100 mM IPTG 616 2.3 304 2.7 438 2.8 
pJacZ-G-7/pACYC-WTT4 100 mM IPTG 215 0.6 296 0.4 467 0.7 
placZ-G-9/pACYC-WTT4 100 mM IPTG 90 1.2 24 2.4 153 1.3 
Table 2: Ji-Galactosidase assays of cells containing gene 44 -lacZ plasmids with 
either pREVl or pACYC-WTT4 vectors. Miller units were calculated for each of the 
cell types. The values for cells with the lacZ plasmid only were divided by the values for 
cells with either pREY! or pACYC-WTT4 to calculate the repression ratio as an 
indication of either RegA of Rev protein's ability to repress lacZ expression from the 
p lasmids containing the different gene 44 RE targets. 
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the color of cells containing placZ-G-9 would be relatively unaffected by the presence of 
the regA plasmid. These results indicate that the repression ability of RegA for specific 
targets in vivo may be difficult to predict from in vitro binding assays. concluded the 
placZ-G-7 vector was suitable for use in the blue-white screen. Cells containing placZ-
G-7 were lighter in color that those containing placZ-RE2. It was hypothesized that some 
mutant RegA proteins might be able to repress the less robust lacZ repression from G-7 
but not be able to repress lacZ expression from placZ-RE2. As with placZ-RE2, the cells 
containing placZ-G-7 or placZ-G-9 showed no significant difference in color 
development between colonies grown on X-Gal plates and those grown on X-GaIlIPTG 
plates. 
1. Random Mutagenesis of the T4 regA gene 
To generate the mutant library for the screen for gain of function mutants the regA 
gene was randomly mutagenized and plasmids expressing the mutant regA gene were 
transformed into cells containing one of the previously modified gene 44 RE-IacZ 
vectors. Subsequently colonies of cells transformed with defective gene 44 target 
plasmids were to be screened for mutations in the regA gene that had regained the ability 
to repress lacZ expression from the defective gene 44 RE and once again produce white 
colonies on X-GAL/IPTG plates. RegA "gain of function" mutants were expected to 
have either altered RNA binding specificity or generally increased RNA binding affinity. 
For the purposes of this study mutants with altered binding specificity should give more 
insight into how RegA protein is able to chose its RNA binding targets and repress the 
expression of genes in the proper temporal sequence. Mutations which alter RegA' s 
binding specificity would be more likely to result in a change in the temporal order of the 
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genes repressed, and thereby, reveal more about the residues involved in interaction with 
specific bases than would mutations which increase RegA' s binding affinity for all 
targets. 
In order to find "gain of function" mutants it was necessary to screen a large 
number of mutant clones. Accordingly, PCR mutagenesis was used to create a library of 
regA clones containing random mutations in the regA gene. The library was generated by 
peR amplification of regA from pAS l-regA plasmid using identical primers to those 
initially used to amplify wild type regA for cloning into pACYC-regA (see materials and 
methods). A mutagenic PCR protocol with increased tolerance for the insertion of 
mismatched bases was used to create random mutations in the regA gene (Cadwell and 
Joyce, 1992). This protocol produces an average of one mutation for every 150-200 base 
pairs of DNA; thus, approximately two mutations per regA gene (366 base pair coding 
region) is expected from this protocol. 
After amplification, the mutagenized PCR products were digested with N de I and 
Sal I and ligated into pACYC-regA vector that had also been cut with Nde I and Sal I. 
The QIAquick ™ Gel purification protocol was used to purify the linearized vector away 
from the restriction fragment containing wild type regA. The ligation mix was then 
transformed into XL I-Blue super competent cells to maximize transformation efficiency. 
The transformed cells were grown overnight in culture, plasmid DNA was extracted and 
saved as a library for use in "gain of function" &creening. 
For the initial screening of the mutant library WMI/placZ-RE2 cells were used as 
a host. As noted previously WMl/F' /placZ-RE2/pACYC-regA (unmutated) colonies are 
blue when grown on X-Gal plates and on X-Gal plates with low concentrations ofIPTG. 
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It was expected that RegA mutants with increased affinity for the RE2 target would 
"gain" the ability to repress lacZ expression in a placZ-RE2 background resulting in 
white or lighter blue colonies grown on X-Gal or X-Gal/low [IPTG] plates. 
WMI/F'/pACYC-RE2 cells transformed with the mutant library were plated on 
both X-Gal and X-Gal/IPTG plates and grown overnight. The plates were then examined 
for white or light blue colonies, as shown in Figure 10. The white or lighter blue colonies 
were selected and grown in liquid culture overnight. Plasmid DNAs were extracted and 
the plasmids were sequenced to identify the mutation responsible for the color change. 
Plasmid DNAs extracted from cells transformed with the mutagenized regA gene were 
labeled pACYC-MT4. 
Five super repressor candidates were selected and sequenced, however, none of 
the five contained the regA gene, mutant or wild type. These results suggested that the 
lack of color initially attributed to RegA repression of lacZ was caused either by a 
defective lacZ gene in the selected colonies or, more likely, the colonies were the result 
of a contaminating bacterial strain that didn't express ~-galactosidase. Since there was a 
high probability of contamination this library was discarded and the mutagenesis was 
repeated to create a new mutant library. 
Also since it appeared that RegA was not efficiently repressing lacZ expression in 
WMI/F' /placZ-RE2/pACYC-reg cells, the synthesis and solubility of RegA protein 
inthese cells was examined. IPTG induced cells were lysed by freeze-thaw procedure, 
and the supernatant and pellet were examined by SDS-PAGE. This analysis indicated 
that the majority of the RegA protein was in the pellet. As noted previously, the pACYC-
regA plasmid expresses a fusion protein of T 4 RegA which carries six residues from the 
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X-Gal X-Gal jlPTG 
Figure 10: Screen for gain of function mutants. WMI/F IplacZ-RE2 cells were 
transformed with pACYC-MT4 and plated on X-Gal and X-GaI/IPTG plates. White or 
lighter blue colonies were selected as potential super repressors (i.e. gain of Function 
mutants). 
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Rev gene. It seemed possible that these six residues could interfere with the proper 
folding of the RegA protein, and thus be responsible for the relative insolubility of the 
protein encoded by pACYC-regA. There was also some concern that the reduced 
solubility of the fusion protein as compared to wild type RegA was adversely affecting 
the blue white screen. The fraction of RegA protein that was misfolded would be unable 
to bind the gene 44 RE effectively resulting in a lower RegA concentration within the 
cell. Accordingly the six amino acid fusion was removed before proceeding with the 
screening experiment. 
As the first step in eliminating the six Rev amino acid residues from the N-
terminus of RegA, site-directed mutagenesis was used to change two bases beginning at 
the -2 position relative to the start codon from "AC" to "CA". This mutation resulted in 
the creation of a new N de I site, "CAT A TG", 18 base-pairs upstream from the original 
Nde I at the beginning of the regA coding sequence. The new Nde I site was positioned 
such that when the plasmid is digested with Nde I restriction enzyme the 18 base pairs 
which encode the six Rev residues are excised from the plasmid. After religation with T4 
ligase the sticky ends from the two original Nde I sites were joined to form a single new 
Nde I site which restored the correct reading frame for regA. Following oligonucleotide-
directed mutagenesis of pACYC-regA, cells were transformed with the mutagenesis 
reaction, plated and grown overnight. Plasmid DNA was extracted and sequenced to 
confirm that the resulting plasmid had the new mutation. The new plasmid was called 
pACYC-regA-2Nde. 
Next pACYC-regA-2Nde was digested with Nde I restriction enzyme to excise the 18 
base pair sequence, and then religated to make the new plasmid pACYC-WTT4 (See 
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Figure 11). Cells were then transformed with the ligation mix, piated, and grown 
overnight. Five colonies were selected and grown overnight. Plasmid DNA was 
extracted and sequenced to confirm that the 18 nucleotide sequence had been deleted. 
Three of the five plasmids were confirmed to have regA sequences without the six 
additional amino acid residues attached to the N -terminus. These three colonies 
containing the new vector encoding wild type regA were grown in liquid cultures 
overnight. Freeze-thaw assays were performed the following day with these cultures and 
samples of the induced cells, uninduced cells, freeze thaw supernatant, and freeze thaw 
pellets were visualized by SDS-PAGE. 
When examined by SDS-PAGE, cultures three and five appeared to overexpress 
T4 regA, but culture number four didn't appear to overexpress regA. The RegA protein 
from T4 cultures three and five appeared to be soluble, although there appeared to be 
much more regA protein in the supernatant of clone number five. There was also a very 
faint band in the supernatant of culture number four. The induction and freeze-thaw gels 
for these cultures are shown in Figure 12. 
Since the SDS-PAGE of the freeze-thaw supernatants indicated that RegA protein from 
both clones three and five were soluble, an EMSA was performed with supernatants of 
clones three and five to see i[RegA protein retained the ability to bind to a 16 mer RNA 
oligo containing the gene 44 RE. The results of this assay are shown in Figure 13. The 
RegA protein in both supernatants bound to the labeled RNA and produced a shift in 
mobility. These result indicate that the proteins from clones three and five are capable of 
binding to the gene 44 RE oligonucleotide. 
Since the wild type regA expressed from pACYC-WTT4 appeared both soluble 
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Figure 11: Creation of pACYC-WTT4. PACYC-regA was modified by site-directed 
mutagenesis to create pACYC-regA-2Nde. This plasmid contained 2 Nde I sites 18 base 
pairs apart and encompassing the same 18 base pairs that coded for the 6 amino acid 
residues fused to the N-terminus of RegA. The plasmid was then digested Nde I 
restriction enzyme and religated to create pACYC-WTT4. 
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Figure 12: Induction and Freeze-Thaw gels ofpACYC ... WTT4 and pACYC-WTRB. 
Upper: SDS-PAGE of induced and uninduced cultures containing pACYC-WTT4 and 
pACYC-WTRB. Cultures 3 and 5 overexpress T4 regA after IPTG induction but culture 
4 does not. RB69 regA is overexpressed after induction but at a lower amount than T 4 
regA. Lower: SDS-PAGE of the freeze-thaw pellet and supernatant of cultures in upper 
gel. T 4 regA proteins in cultures 3 and 5 are soluble as is RB69 regA. The band in 
culture 4 appears to run slightly higher in the gel than regA protein. 
No No T4 T4 V'JT WT 
regA regA regA regA T4 T4 
# 3 #5 




Figure 13: Gel mobility shift assay of wild type T4 RegA. The supernatants of T4 
RegA cultures three and four both cause a shift with the 32p labeled RNA oligo of gene 
44 RE, demonstrating the RegA proteins from these cultures are capable of binding the 
gene 44 RE target. 
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and capable of binding RNA, a new mutant library was generated. The same mutagenic 
PCR and ligation protocol as used in the previous experiment was used to create the new 
library. As the previous attempt had been unsuccessful in finding "gain of function' 
RegA mutants in WMI/F' /placZ-RE2 cells, WMI/F' /placZ-G-7 cells were used for this 
experiment. It was hoped that super repressor mutations could be found that would result 
in white colonies when the library was screened. 
2. Selection and Characterization of Potential "gain of function" Mutants. 
After the peR the mutant regA product and pACYC-WTT4 plasmid were 
digested with the restriction enzymes Nde I and Sal I, and subsequently both were gel 
purified to remove unwanted DNA. Next, cut plasmid and regA insert were ligated 
overnight with T4 DNA ligase. WMl/F' cells were transformed with the ligation mix, 
plated on LB agar and grown overnight. Approximately 1000 colonies were screened on 
16 transformation plates. Forty lighter blue or white colonies were selected as potential 
super repressors. These colonies were grown in 3 ml cultures overnight and then 
streaked onto X-Gal and X-Gal/IPTG plates to confirm that these cells exhibited 
differences in color. At the same time new cultures of each of the super repressor 
candidates were grown to an OD of .800 and induced overnight for freeze-thaw lysis and 
subsequent analysis by SDS-PAGE and EMSA. Additional cultures of each potential 
super repressor were grown overnight for plasmid DNA extraction. After overnight 
growth the streak plates were examined for color differences, induced samples were 
examined using SDS-PAGE, and plasmid DNA was extracted and sequenced. The streak 
plates and Induction gel for the first eight of the potential super repressors are shown in 
Figure 14. 
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Half of the potential super repressors shown in Figure 14 did not show a 
difference in color when plated on X-GAL and X-GAL/IPTG plates. For the total group 
of 40 potential super repressors almost two thirds of the clones did not contain an 
inducible regA gene. Each of the inducible clones were sequenced, and three different 
mutations were identified. The three mutations were Valine 15 to Glutamic Acid 
(VI5E), Alanine 75 to Glutamic Acid (A 75E), and a truncation at residue 106 (FI06X). 
Isolates of each these three mutants were found multiple times. The highly expressed 
clones shown in Figure 14 contain examples of each of the different mutants found in this 
study. Clone number two is A 75E; clones three and four are both F I 06X; and clone 
number five is VI5E. 
Gel mobility shift assays were performed using the freeze-thaw supernatants of the three 
mutants and surprisingly there was no detectable RNA shift indicating little or no binding 
to the RNA target. Based on this assay and the high levels expression in the induced cells 
it was decided that these mutants were not the expected "gain of function" mutants but 
instead were mutants with a lower affinity for RNA. Repression of lacZ expression most 
likely was achieved by overexpression of the mutants, made possible because the mutant 
RegA were less toxic to the cells than wild type RegA. If so, the mutants had the ability 
to repress lacZ expression, but not in a manner that could yield useful information about 
the binding site of RegA protein for its RNA target. 
C. Comparison ofT4 and RB69 RegA Proteins' Activities in vivo 
Previous work by other researchers had shown that the RegA homologue found in 
the bacteriophage RB69 could bind to T4 RNA binding targets, and suggested that RB69 
RegA had a higher affinity for synthetic T4 gene 44 RE RNA than did T4 RegA itself 
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Induction Gel 
1 2 3 4 
Figure 14: Identification of T4 mutants from blue-white screen. Upper: Streak plates 
of potential super repressors from blue white assay of mutant library. Lower: Induction 
gel of cultures grown from same colonies as shown on streak plates. Note that color 
changes in streak plates correspond to highly induced clones on the gel. 
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(Joswik and Miller, 1992; Sengupta et aI., 2000). Using gel mobility shift assays RB69 
RegA protein's affinity for the T4 gene 44 RE RNA was calculated to be approximately 
7-8 times that of T4 RegA (Sengupta et al., 2000). The higher affinity for the gene 44 
target meant that RB69 RegA was, in essence, a super repressor when compared to T4 
RegA. This suggests that RB69 RegA could possibly be used as a positive control for 
super repressors in future experiments. To determine if the increased affinity of RB69 
RegA for the gene 44 RE observed in vitro resulted in phenotypic differences in vivo the 
RB69 regA gene was cloned into pACYC and the effects of RB69 RegA on lacZ 
expression was examined. 
1. Construction and Characterization ofpACYC-WTRB 
The RB69 regA gene was amplified from the plasmid pJG4 and then ligated into 
the pACYC plasmid with the same cloning procedure that had been used to create the 
original pACYC-regA plasmid. First the RB69 regA gene was amplified from the 
plasmid pJG4 with complementary primers that generated a Nde I/Sal I fragment 
containing the RB69 gene. The RB69 regA PCR product and the pACYC plasmid were 
both digested with Nde I and Sal I and gel purified to remove DNA fragments excised by 
the digest. The RB69 gene was then ligated into pACYC with T4 ligase. The ligated 
plasmid was transformed into XL I-Blue supercompetent cells, plated, and grown 
overnight. Only one colony was generated from the transformation, but after extracting 
the plasmid DNA, sequence analysis indicated the plasmid contained the wild type RB69 
reg A gene. The new plasmid was named pACYC-WTRB and subsequently transformed 
into WMI/F' cells containing each of the following placZ plasmids: II B, 44RE, RE2, G-
7, and G-9. Following transformation, WMI/F'/placZ-RE2/pACYC-WTRB cells were 
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induced with IPTG overnight and a freeze-thaw assay was performed. When induced 
with IPTG the cells overexpressed RB69 regA, but at a lower level than T4 regA 
expressed in identical WM1/F'/placZ-RE2/pACYC-WTT4 cells. SDS-PAGE analysis of 
the freeze-thawed cells containing pACYC-WTRB also demonstrated a band for RB69 
RegA, again indicating lower levels than in the cells expressing T4 regA. Since RB69 
was expressed in a soluble form in these cells, an in vivo comparison of WM1/F' IplacZ-
RE2 cells containing pACYC-WTT4 and pACYC-WTRB was made. 
2. In vivo comparison of T4 and RB69 regA proteins' repression of gene 44 
RE-lacZ expression. 
As a preliminary comparison of the ability of RB69 and T4 RegA proteins to 
repress lacZ expression, streak plates were made with side by side streaks of 
WM1/F'/placZ-RE2/pACYC-WTT4 cells and WM1/F'/placZ-RE2/pACYC-WTRB 
cells. The streaks were made onto 4 X-Gal plates with IPTG concentrations of 0, 10, 
100, and 1000 J,lM. Unfortunately, the adverse selection for non-functional mutants made 
determination of wild type RB69 protein's repression ability by color screening 
unreliable. Therefore, these efforts were discontinued. 
Alternatively, the ability of RB69 RegA to repress lacZ expression was compared 
by ~-galactosidase assays of liquid cultures. The same procedure was followed for this 
assay as was used in the B-galactosidase assay with T 4 RegA. The only difference was 
the WM 1 IF' cells containing the different placZ plasmids were transformed with 
pACYC-WTRB instead of pACYC-WTT4. The results of these assays, shown in Table 
3, demonstrate that RB69 RegA does show increased repression ability in comparison 
with T 4 RegA. This increase in repression ability is demonstrated consistently with each 
of the gene 44 RE variants tested. Comparison of the results shown in Table 3 with those 
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Beta-Galactosidase Assays 
4/22/00 4/27/00 5/23/00 
Miller Repression Miller Repression Miller Repression 
Cell Type Units Ratio Units Ratio Units Ratio 
placZ-IIB 100 mM IPTG 366 *** 443 *** 403 *** 
placZ-44RE 100 mM IPTG 177 *** 74 *** 172 *** 
placZ-RE2 100 mM IPTG 1439 *** 812 *** 1227 *** 
placZ-G-7 100 mM IPTG 137 *** 113 *** 327 *** 
placZ-G-9 100 mM IPTG 108 *** 59 *** 199 *** 
placZ-IlB/pREVl 100 mM IPTG 392 n.~ 66 6.7 679 0.6 
placZ-44RE/pREVl 100 mM IPTG 247 0_7 79 0.9 210 0.8 
placZ-RE2/pREVl 100 mM IPTG 442 3.3 624 1.3 1668 1.0 
placZ-G-7/pREVl 100 mM IPTG 294 0.5 141 0.8 338 1.0 
placZ-G-9/pREV I 100 mM IPTG 284 0.4 195 0.3 195 1.1 
placZ-IIB/pACYC-WTRB 100 mM IPTG 439 0.8 435 1.0 338 1.2 
placZ-44RE/pACYC-WTRB 100 mM IPTG 161 1.1 148 0.5 205 0.8 
placZ-RE2/pACYC-WTRB 100 mM IPTG 298 4.8 306 2.7 300 4.1 
placZ-G-7 /pACYC- WTRB 100 mM IPTG 228 0.6 73 1.5 189 1.7 
placZ-G-9/pACYC-WTRB 100 mM IPTG 257 0.4 90 0.7 123 1.6 
Table 3: Beta-Galactosidase Assays of Cells Containing Plasmids With Variant 
Gene 44 REs only with or without pREVl or pACYC-WTRB. Miller units were 
calculated for each of the cell types. The values for cells with the lacZ plasmid only were 
divided by the values for cells with either pREY! or pACYC-WTRB to calculate the 
repression ratio as an indication of either RegA of Rev protein's ability to repress lacZ 
expression from the plasmids containing the different gene 44 RE targets. 
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for T4 RegA shown in Table 2 demonstrate that the repression ability of RB69 RegA is 
consistently greater than that of T4 RegA with each of the lacZ plasmids tested. 
DISCUSSION 
The study presented in this thesis was intended to provide new insights into how 
RegA protein functions as a translational repressor. The objectives of this study were: 1) 
to test whether the ability of regA to distinguish between wild type and selected variants 
of the gene 44 RE is functionally relevant to in vivo repression of gene expression, 2) to 
identify mutants of T4 RegA that have altered RNA binding specificity, and 3) to 
determine whether differences between RB69 and T4 RegA proteins' repression of gene 
44 in vitro are consistent with functional activities in vivo. Observations from the in vivo 
studies described here, which were performed to answer these questions, have provided 
new information concerning the function and behavior ofT4 RegA protein. 
The T4 gene 44 recognition element confers sensitivity to RegA repression on 
the LacZ gene in vivo. Earlier studies of RegA protein binding to gene 44 mRNA 
suggested that RegA recognizes a short, 12 nucleotide sequence upstream of the gene 44 
AUG start codon (\\Tebster and Spicer, 1990). To determine the contributions of 
individual bases of the gene 44 RE to RegA binding affinity, (Webster and Spicer, 1990) 
determined the in vitro binding affinities of RegA for selected gene 44 RE variants. 
However, measured affinities of RegA protein for short synthetic RNAs may not be 
directly related to repression activities observed in vivo because of the effects of 
neighboring nucleotides sequences or structures and unrelated effects on the affinity of 
ribosomes which compete with RegA protein for binding to an mRNA. To see if the 
results of previous studies of RegA protein affinity for short synthetic RNAs are 
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reflective of RegA activity in vivo, the ability of RegA to act in trans to repress 
translation of a gene 44 RE-IacZ fusion gene was explored. For these in vivo studies, the 
ability of RegA to repress a fusion gene carrying the 12 nucleotide sequence 
AAUGAGGAAAUU(AUG) fused to lacZ was studied. In addition, the ability of Reg A 
to repress expression of a 0-9 variant of gene 44 RE was examined because in vitro this 
mutation reduced the binding affinity of T4 RegA to that of non-specific RNA. The G-7 
variant was selected because it demonstrated a binding affinity approximately halfway 
between that of wild type and 0-9. Cells containing plasmids placZ-IIB and placZ-44RE 
were also compared in this study. PlacZ-IIB served as a control because it did not 
contain a binding site for RegA and placZ-44RE was included to determine the effect on 
RegA binding of a stem-loop structure which preceded the gene 44 RE . 
The results of B-galactosidase assays performed with WM 1 IF' cells carrying 
pACYC-WTT4 and the placZ plasmids, lIB, 44RE, RE2, G-7, and G-9 are summarized 
in Table 4. The data in Table 4 present the RegA repression ratios from a single 
experiment and the average of three experiments presented in the RESULTS section, 
above. As shown in Table 4, expression of RegA in cells containing the pLacZ-44RE2 
vector led to a 2.6 fold repression of lac Z expression, while no repression was observed 
in pLacZ-lIB cells or pLacZ-44 RE cells. The lack of repression with pLacZ-lIB 
demonstrates that the repression is specific for genes containing the gene44 recognition 
element. The absence of repression with pLacZ-44RE indicates that the presence of a 
stem and loop structure immediately preceding the gene 44 recognition element precludes 
RegA repression of the fusion gene. Interestingly, introduction of a 0-7 mutation in the 
gene 44 RE (Table 4) eliminated RegA repression, while the G-9 mutation in the 
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recognition element reduced the repression ratio from 2.6 to 1.8. Although these are 
only modest effects on repression, they are consistent with the predictions based on the 
effects of single base substitutions in the gene 44 RE on in vitro RNA binding affinities. 
Thus, these studies demonstrate that in the context of a full mRNA, RegA protein 
recognizes the 12 nucleotide gene 44 recognition element and retains the ability to 
distinguish between WT, G-9 and G-7 variant RNAs. This confirms that, unlike most 
other translational repressors, RegA protein recognizes a short, single stranded RNA 
sequence which is sufficient to confer sensitivity to translational repression in vivo. 
Table 4. Repression of lacZ translation by T4 RegA protein. 
f3-galactosidase Repression Average 
activity'" ratio* Repression 
Reporter plasmid No RegA pT4RegA ratioC!) 
plasmid 
pLacZ-IIB 366 323 1.1 0.9 
pLacZ-44RE 176 279 0.6 0.6 
pLacZ-44 RE2 1439 615 2.3 2.6 
pLacZ-44G-7 137 215 0.6 0.6 
pLacZ-44G-9 108 90 1.2 1.8 
'" ~-ga1actosidase activity is reported in Miller units. 
*Repression ratios are the ratio of ~-galactosidase activity in cells containing pLacZ 
vectors alone over activity in cells containing the pLacZ vector plus pRegA. Values are 
from a single experiment. 
C!) Values are the average of repression ratios from three experiments. 
The toxicity of RegA protein for the host cells make the two-plasmid system 
and blue-white screening procedure an unsuitable method for identifying "gain of 
function" RegA mutants. As previously described, a two-plasmid system was designed 
to allow the rapid screening of a large number of bacterial colonies expressing mutant T4 
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proteins. Two major difficulties, which were not overcome, resulted in the determination 
that this assay was not suitable for finding regA mutants with increase binding affinity. 
The first problem was the adverse selection for RegA mutants with reduced RNA 
binding affinity because of the toxicity of RegA protein for the host cells. This toxicity 
necessitated the use of low levels of IPTG to induce RegA synthesis for these 
experiments in an attempt to avoid killing cells containing functional RegA. In an effort 
to find a level of gene induction that would not affect the growth of the cells and 
therefore not select for the unwanted mutants, the growth curves of WMI/F'/placZ-
RE2/pACYC-regA cells were measured at different IPTG concentrations and compared 
with the growth of WMI/F'/placZ-RE2 cells without RegA. As shown in Figure 6, no 
level of IPTG induction was found that did not affect cell growth. In fact even in the 
absence of IPTG, the presence of the regA plasmid resulted in a significantly lower 
growth rate than that observed in identical cells without the regA plasmid. 
Although the toxicity of RegA was a concern it was felt that this problem could 
be avoided by the use of low levels of IPTG for the screen. The mutation types expected 
to result in white colonies were: 1) mutants with an overall increase in RNA binding 
affinity and 2) mutants with an altered binding specificity resulting in increased affinity 
for the particular gene 44 RE sequence contained in the lacZ plasmid. Either of these 
mutant types could potentially be of interest or benefit in defining the binding site for 
RNA on the RegA protein, but mutants with altered binding specificity would be of more 
interest. Mutants of this type could give insight not only into the RNA binding site but 
also to the method by which T4 RegA protein determines the hierarchy of its RNA 
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binding preference. Mutants with reduced binding affinities were expected to be blue and 
not interfere with the selection process. 
The results of the experiments were different from those anticipated and this 
difference demonstrated the second and more critical problem which made the blue-white 
screen unsuitable for selecting mutants with increased binding affinity for RNA. Mutants 
chosen using the blue-white selection process were not "gain of function" mutants. As 
detailed above in the RESULTS section, a number of white or light blue colonies were 
selected as potential gain of function mutants. After additional screening and 
characterization three different mutations were identified. For each of these mutants, a 
freeze-thaw procedure was performed and the resulting supernatants were examined by 
EMSA. There was no detectable RNA shift caused by these mutants. These results 
suggest that even though the mutant proteins were able to repress lacZ expression in vivo, 
their binding affinity was too low to be detected in normal gel shift assays. SDS-P AGE 
analysis of the induced and uninduced mutant cells suggest that this repression is due to 
the ability of the mutant proteins to be highly over expressed without harming the host 
cells. Thus, the mutants selected in this assay do not appear to be informative for RegA 
structure/ functi on studi es. 
RB69 RegA protein translationally represses a lacZ fusion gene carrying the 
T4 gene 44 recognition element. The phylogenetically related RB69 phage encode a 
RegA protein that is 220/0 divergent in sequence from T4 RegA protein. Earlier studies of 
Joswik and Miller (1992) suggested that RB69 RegA protein is capable of repressing 
phage T4-encoded mRNAs, including gene 44, gene 45 and rpbA. These studies 
suggested that RB69 RegA repressed the three T4 mRNAs, and protein synthesis in 
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general, more efficiently than T4 RegA protein. Although the RegA recognition element 
in RB69 gene 44 is not known, the sequence of the translation initiation region of RB69 
gene 44 has three-nucleotide insertions relative to the T4 gene 44 TIR. To see if RB69 
RegA protein recognizes the same sequence in T4 gene 44 as T4 RegA protein, the 
ability of RB69 RegA to repress the translation of the gene 44-lacZ fusion gene carried 
on placZ-44RE2 was examined. As shown in Table 5, below, the presence of RB69 
RegA in cells carrying placZ-44RE2 resulted in repression of ~-galactosidase synthesis. 
Thus, the 12 nucleotide sequence of T 4 gene 44 confers sensitivity to repression by RB69 
RegA. Interestingly, this repression of gene44-lacZ was consistently higher than 
repression by T4 RegA protein. This is in agreement with the higher affinity of RB69 
RegA protein for gene 44 RE RNA measured in vitro (Sengupta et al., 2000) and the 
report ofRB69 RegA repression ofT4 mRNAs by Joswik and Miller (1992). 
Table 5. Repression of lacZ translation by RB69 RegA protein. 
~-galactosidase Repression Average 
activity ratio* 
. repress10n 
Reporter plasmid No RegA pRB69 ratio\jl 
plasmid RegA 
pLacZ-IIB 402 338 1.2 1.0 
pLacZ-44RE 172 205 0.8 0.9 
pLacZ-44RE2 1226 300 4.1 4.0 
pLacZ-44G-7 327 189 1.7 1.2 
pLacZ-44G-9 199 123 1.6 1.3 
*Repression ratios are the ratios of ~-galactosidase activity in cells containing 
pLacZ vectors alone over activity in the same cells containing pRegA. Values are 
from a single experiment. 
\jI Values are the average of repression ratios from three experiments. 
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As Table 5 shows, repression by RB69 RegA protein was significantly lower in 
cells containing plasmids carrying the G-7 and G-9 mutations in the gene 44 RE. Thus, 
although the two proteins have a number of divergent surface residues, these studies 
suggest that RB69 regA protein shares the ability of T 4 RegA protein to distinguish 
between WT, G-7 and G-9 variants of the gene 44 RE. While the two proteins have 
conserved helix-loop groove RNA binding motifs (Sengupta et al., 2000), presumably 
some of the divergent residues contribute to the higher binding affinity for gene 44 RE 
RNA seen here. These studies confirm the ability of RB69 RegA to repress 
translation of T4 gene 44 mRNA in vivo and show, for the first time, that this 
repression is conferred by the 12 nucleotide sequence 5'-AAUGAGGAAAUUA-3. 
Additional studies will be needed to determine how RB69 RegA protein achieves the 
higher affinity for T4 gene 44 RE than T4 RegA and how the differences in sequences 
between T4 and RB69 mRNAs related to their repression in vivo. 
CHAPTER II 
I. INTRODUCTION 
A. Aryl Hydrocarbon Receptor 
1. Background and History 
As early as the 1950's it was found that rodents exposed to polycyclic aromatic 
hydrocarbons (PAHs) responded with what was then known as aryl hydrocarbon 
hydroxylase (AHH) activity (Conney et aI., 1956; Schmidt and Bradfield, 1996). Genetic 
studies revealed that AHH activity in response to P AHs varied greatly among inbred 
mouse strains (Nebert and Gelboin, 1969), with C57 strains labeled as highly responsive 
and DBA and AKR strains being considered non-responsive (Schmidt and Bradfield, 
1996). Multiple alleles at a single locus were eventually determined to be responsible for 
the variations in AHH response, and were termed the Ah locus (Green, 1973; Thomas 
and Hutton, 1973; Schmidt and Bradfield, 1996). It was later found that 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) could elicit a vastly increased level of AHH activity 
from the responsive strains and even elicit activity in the supposedly non-responsive 
strains. The existence of a soluble protein with receptor-like properties was first 
confirmed using radiolabeled TCDD (Poland and Glover, 1976). The protein was termed 
the aryl hydrocarbon receptor (AHR) since it was encoded by the Ah locus. Eventually 
it was determined that an AHR was also expressed In non-
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responsive strains, although it exhibited significantly lower affinity for ligand than that 
found in the responsive strains (Okey et al., 1989; Poland et al., 1994). 
2. Localization and Protein Associations 
The AHR is an ubiquitously expressed protein, and in the absence of ligand, is 
generally found in the cytoplasm in an inactive multiprotein complex that minimally 
consists of the AHR protein itself along with two molecules of hsp90 (Perdew, 1988; 
Pollenz et ai., 1994: Holmes and Pollenz, 1997). Crosslinking, sedimentation, and other 
experiments have also indicated the presence of an additional 37-43 kDa protein 
associated with this complex (Chen and Perdew, 1994). Additionally, a 330 amino acid 
protein with sequence similarity to a 52 kDa immunophilin co-activator of the 
glucocorticoid receptor, has been shown to bind preferentially to ligand activated AHR 
(Carver and Bradfield, 1997; Ma and Whitlock, 1997). 
The AHR by itself is not sufficient to mediate gene expreSSIon through the 
xenobiotic response elements (XREs). Before this can occur, AHR must form a 
heterodimer with the aryl hydrocarbon receptor nuclear translocator protein (ARNT). In 
spite of its name, ARNT is not involved in the translocation of AHR to the nucleus. 
ARNT is a constitutively expressed bHLH/P AS protein localized to the nucleus (Pollenz 
et al., 1994; Hord and Perdew, 1994) where it exists as a homodimer. Although it was 
initially discovered as a component of the AHR signal transduction pathway (Reyes et 
aI., 1992), ARNT has been shown to form complexes with other bHLH/P AS proteins 
such as SIM and HIF -1 a to mediate biological responses in those pathways (Li et al., 
1996; McGuire et aI., 1996). 
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When activated by ligand, the AHR complex translocates to the nucleus. Once in 
the nucleus the AHR protein can either dimerize with ARNT or be translocated back to 
the cytosol. The AHRI ARNT dimer mediates gene expression by binding to the XRE 
(Jones et aI., 1986; Hankinson, 0, 1993; Whitlock, lR., 1993; Whitlock, J.R., 1999: 
review articles). The XREs are regions of DNA recognized by the AHR/ARNT 
heterodimer. Multiple XRE sequences, (5'-TNGCGTG-3'), are located in the upstream 
promoter region of all genes regulated by the AHR signal transduction pathway (Denison 
et al., 1988; Denison et al., 1988). The CYP1A1 gene is the best known example of a 
gene whose expression is mediated through AHRI ARNT binding to XREs. Mutational 
analysis has shown that the (5' -CGTG-3') motif is required for inducible AHRI ARNT 
dependent protein-DNA interactions at the enhancer site (Shen and Whitlock, 1992; 
Whitlock, 1999). Additionally photo-crosslinking studies and mutational analysis have 
indicated that AHR binds to the TNGC sequence of the enhancer, and that ARNT binds 
to the GTG half-site (Bacsi et at., 1995). 
3. Structure and Domains 
AHR is a ligand-activated transcription factor that belongs to the growing family 
of basic helix-Ioop-helixlPER-ARNT-SIM (PAS) proteins (Em a et al., 1992; Burbach et 
aI., 1992, Whitlock, lP" 1999). In addition to the three namesake transcription factors, 
other members of this family include a number of mammalian and Drosophila proteins 
(Schmidt and Bradfield, 1996,), as well as the hypoxia inducible factor (HIF -1 a) and 
coacti vator proteins such as S rc-1 (Onate et al., 1995). 
75 
Figure 15: Schematic View of the Functional Domains of the Aryl Hydrocarbon 
Receptor: The AHR protein contains a number of domains which overlap in function. 
The Basic region is the section of the protein primarily involved in DNA binding, but it 
also encompasses the NLS sequence. This theme of overlapping function is again seen in 
the helix-loop-helix region which is primarily responsible for the ability of AHR to 
dimerize with its co-activatior ARNT. The NES sequence is contained within helix two 
of this domain. The PAS region consists of the A and B boxes and again the theme of 
overlapping function occurs. The B box functions in both ligand binding and Hsp90 
binding. The Q-Rich region is rich in glutamines and is primarily responsible for the 
transactivation ability of the AHR protein. 
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The AHR can be divided into a number of functional domains or regIons (see 
Figure 1). These domains include: 1) the N-terminal nuclear localization signal (NLS) 
region, 2) the basic region, 3) helix-loop-helix domain, 4) the nuclear export sequence 
(NES) region,S) the PER-ARNT-SIM (PAS) domain, 6) the ligand binding region, 7) the 
hsp90 binding region, 8) the C-terminal transactivation domain. The regions are listed as 
much as possible in their sequence order, N-terminus to C-terminus, although there is 
some overlap. For example, the NES sequence is located on the second helix of the 
helix-loop-helix domain. 
The minimal NLS sequence for AHR has been identified as sequence of 27 amino 
acid residues, numbering 13-39 in the protein sequence (Ikuta et aI., 1998). This 27 
residue sequence is described as a bipartite NLS (NLS signals are discussed in detail in 
part 2 of the Introduction) with basic amino acid residues clustered at both the 5' and 3' 
ends of the signal. Mutating either of the basic residues located at positions 13-15 or 37-
38 resulted in complete loss of translocation to the nucleus in experiments with this 
sequence fused to green fluorescent protein (GFP) or glutathione S-transferase (OST) 
(Ikuta et al., 1998). 
The basic region and the helix-loop-helix (HLH) domain are often referred to as the 
basiclhelix-Ioop-helix (bHLH) domain, but the two regions have distinct and separate 
functions. The basic region consists of residues 27-39 (Burbach et al., 1992; Fukunaga et 
aI., 1995) and is therefore completely overlapped by the NLS signal previously 
discussed. It is this region that is responsible for the DNA-binding ability of the AHR 
(Fukunaga et al., 1995). The HLH domain consists of residues 40-79. This domain has 
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been shown to be necessary for dimerization with the co-activator protein ARNT 
(Fukunaga et aI., 1995). 
The NES region or signal, as previously mentioned, is located inside the HLH 
domain. This is a leucine rich sequence of amino acid residues and is located on the 
second helix of the HLH domain. The residues included are numbered 63-73 with the 
sequence KLDKLSVLRLS (Gerace, 1995; Ikuta et al., 1998; Davarinos and Pollenz, 
1999). 
The PAS domain includes amino acids 120-384 and contains two 51 amino acid 
repeat sequences of high similarity to regions found in the PER, ARNT, and SIM 
proteins (Burbach et al., 1992). The PAS part of this region consists of the two repeat 
sequences, PAS A and PAS B, but region also encompasses the hsp90 binding domain 
and overlaps most of the ligand binding region. The PAS domain has also been shown to 
be important in dimerization (Fukunaga et al., 1995). Deletion analysis has mapped the 
hsp90 binding region to an area including amino acid residues 162-374, and the ligand 
binding region to residues 230-397 (Fukunaga et aI., 1995). Once again areas of the 
protein responsible for differing functions overlap. 
The C-tenninal transactivation domain is, as the name implies, responsible for the 
transactivation properties of AHR. This region includes a glutamine rich sequence and 
surrounding sequences. Deletion analysis has shown the amino acid residues 490-805 to 
be necessary for transactivation (Fukunaga et aI., 1995). Other studies of the carboxy 
half of the AHR have shown similar though not identical results (Dolwick et aI., 1993; 
Whitelaw et aI., 1994) 
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4. Degradation 
It has been shown that ligand binding results in the rapid depletion of the AHR 
protein both in vivo and in vitro. AHR protein is reduced by 80-95% in numerous cell 
culture models within four hours of TCDD exposure and AHR protein remains depleted 
as long as ligand is present in the media (Pollenz, R.S., 1996; Giannone et a!., 1995; 
Giannone et al., 1998). In vivo experiments have also shown AHR protein to be 
dramatically reduced in the following: male reproductive tissues, spleen, thymus, liver, 
and lung of rats given a single oral dose of TCDD (Pollenz et a!., 1998). AHR was also 
shown to be reduced in male reproductive tissues of rats exposed to TCDD in utero and 
lactationally (Sommer et a!., 1999). 
In experiments with cultured cells, western blot analysis has shown that the AHR 
protein concentration detected in nuclear lysates is highest following one hour of TCDD 
exposure but then rapidly declines (Pollenz et aI., 1994; Pollenz, R.S. 1996). 
Additionally, gel mobility shift analysis shows that the association of the AHR-ARNT 
complex with the XRE is transient and the number of complexes associated with the XRE 
is greatly reduced in cell culture models within 2-6 hours after ligand exposure (Pollenz et 
aI., 1998; Reick et al., 1994). 
Recent studies with cultured cells treated with dioxin and the proteasome inhibitor 
MG-132 have shown that degradation of the AHR protein is inhibited in MG-132 treated 
cells (Davarinos and Pollenz, 1999). These results indicate that AHR degradation occurs 
in the cytoplasm, via the proteasome, after being exported from the nucleus. 
Furthermore, treatment of cells with leptomycin B, a global inhibitor of nuclear export, 
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prevents the rapid degradation of the AHR protein, and results in a sustained 
accumulation of AHR in the nucleus of a number of different cell types (Davarinos and 
Pollenz, 1999). Results similar to those seen with leptomycin B treatment were also 
obtained using AHR proteins with non-functional nuclear export sequences (NES) 
(Davarinos and Pollenz, 1999; Pollenz and Barbour, 2000). 
Additional new studies have shown that the AHR protein degradation is inhibited 
by treatment of cells with cyclohexamide with resulting superinduction of CYP 1 A 1 gene 
expression (Ma et aI., 2000). However, cyclohexamide has been shown to block protein 
synthesis at the concentrations necessary for superinduction and inhibition of AHR 
degradation. This information has led to the hypothesis that cyclohexamide treatment 
blocks the synthesis of a protein necessary for the degradation of AHR putatively called 
AHR degradation promoting factor (ADPF) (Ma et aI., 2000). Further studies have 
shown that AHR is targeted for degradation by ubiquitin and that blocking 
ubiquitinization produced similar results to those obtained in cells treated with the 
proteosome inhibitor MG-132 (Ma and Baldwin, 2000). 
These multiple observations that AHR protein must re-translocate to the cytoplasm, and 
that AHRI ARNT dimers bound to DNA increase when export to the cytoplasm is 
blocked give new insight and greater detail to the AHR signal transduction pathway (see 
Figure 2). These observations combined with the information that CYPIAI gene 
expression is increased when AHR degradation is inhibited also suggest that the that the 
degradation of the AHR may be an additional mechanism for the regulation of gene 
expression via this pathway. 
I ACTIVE NUCLEAR I 
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Figure 16: Graphic representation of the Aryl Hydrocarbon Pathway: Prior to 
agonist exposure AHR exists as an inactive multiprotein complex in the cytoplasm of the 
cell. Upon introduction of agonist the AHR complex translocates to the nucleus. Inside 
the nucleus AHR can dimerize with its co-activation partner ARNT. The AHRI ARNT 
complex can then bind to the XRE sequence and induce gene expression. Alternatively 
the AHR protein can be exported back to the cytoplasm where it is degraded by the 
proteosome. 
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B. Nuclear transport 
1. General overview 
Nuclear export and import are both major cellular processes. All nuclear proteins 
are made first in the cytoplasm and then must be imported into the nucleus while almost 
all RNA molecules and messages must be exported to the cytoplasm for translation. Still 
other proteins are thought to shuttle continuously between the nucleus and cytoplasm. 
Conservative estimates have suggested that more than one million macromolecules are 
transferred between the two compartments each minute in a growing mammalian cell 
(Gorlich and Mattaj, 1996; Mattaj and Englmeier, 1998). All of this traffic is believed to 
pass through the nuclear pore complexes (NPCs), which are huge structures that form 
aqueous channels penetrating the double lipid bilayer of the nuclear envelope (Mattaj and 
Englmeier, 1998). The NPCs are huge structures consisting of 50-100 individual 
polypeptides generically referred to as nucleoporins (Rout and Blobel, 1993). Together 
these proteins form a channel that permits the diffusion of small molecules and even some 
proteins smaller than 60 kDa approximately nine nanometers in diameter. 
Although diffusion of small proteins and RNAs is possible, in practice there are 
few proteins and no RNAs that are known to do this. Instead, nuclear transport, of 
proteins and nucleic acids, is accomplished primarily by active transport, an energy 
dependent process that is essential for transport of RNA and protein across the nuclear 
membrane (Daneholt B., 1997; Mattaj and Englmeier, 1998). The pore size for active 
transport through the NPC is almost triple in diameter, 25 nanometers, when compared to 
that of unassisted transport or diffusion, nine nanometers (F eldherr et al., 1984; Mattaj 
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and Englmeier, 1998). Large conformational changes in the NPC must occur to allow 
transport of larger molecules. 
As one can imagine an important aspect of nucleocytoplasmic transport is making 
certain that the molecules undergoing transport end up in their proper location in the cell. 
Nuclear proteins must be localized to the nucleus and cytosolic proteins must find their 
way to the cytosol so that they may perform their proper functions. Some proteins, the 
previously discussed AHR for example, must move from one cellular compartment to 
another to function properly. Cells have evolved mechanisms to insure that the various 
proteins are in their proper location within the cell. Energy in the form of ATP is 
required to allow the necessary changes in conformation (Michael et aI., 1995; Shulga et 
aI., 1996) 
2. Nuclear Import 
Proteins are targeted to the nucleus by means of a Nuclear Localization Signal 
(NLS). While proteins use a number of different signals to direct their translocation into 
the nucleus two of the better defined signals are: 1) the simple basic NLS typified by the 
SV 40 large T antigen NLS and, 2) the bipartite basic NSL similar to the nucleoplasmin 
NLS (Kalderon et al., 1984; Mattaj and Englmeier, 1998). A number of other signals such 
as the M9-domain, a glycine and aromatic rich region, found in human hmRNP AI, and 
the KNS found in human hmRNP K have been identified but, as yet, are not completely 
characterized or understood (Mattaj and Englmeier, 1998). 
While the NLS is the tag that targets a protein to the nucleus, the process of 
nuclear import is mediated through the action of a number of nuclear pore associated 
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receptor and adapter proteins collectively known as importins. Two of the better known 
and characterized proteins of these types are, importin a ( adapter), and, importin ~, 
(receptor). Importin a was first identified as a protein found in reticulocyte lysate that 
could be crosslinked to the SV 40 Tag NLS, and that functioned in nuclear import with a 
second protein (Adam et af., 1989; Adam and Gerace, 1991; Adam and Adam, 1994; 
Mattaj and Englmeier, 1998). In later studies first importin a and then importin b were 
cloned (Gorlich et af., 1994; Enenkel et al., 1995). These two proteins form an a/~ 
heterodimer and the importin a subunit binds to the NLS region of the protein to be 
transported, and the importin ~ interacts with the NPC (Adam et af., 1989; Adam and 
Gerace, 1991; Adam and Adam, 1994; Moore and Blobel, 1992; Gorlich et af., 1995; 
Moroianu et af., 1995; Mattaj and Englmeier, 1998). While formation of the 
protein/importin a/~ complex and docking with the NPC is energy independent, the 
actual translocation to the nucleus is energy dependent (Richardson et al., 1988; 
Newmeyer and Forbes, 1988). Ran GTPase and a number of other proteins are required 
for GTP hydrolysis and translocation to the nucleus (Mattaj and Englmeier, 1998). Ran 
with GTP bound binds to importin ~ and releases the imported protein from the importin 
complex. 
3. Nuclear Export 
While nuclear import most likely consists primarily of the transport of individual 
proteins or protein complexes, this does not hold true for nuclear export. Since all 
proteins are transcribed in the cytoplasm, a major function of nuclear export involves the 
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translocation of RNA molecules to the cytosol. The export of the RNA molecules has 
been shown to be mediated by adaptor proteins that bind to the RNA molecules and are 
in tum recognized by the nuclear export proteins or exprotins, such as CRM 1 and CAS 1 
(larmolowski et al., 1994; Pokrywka and Goldfarb, 1995; Mattaj and Englmeier, 1998). 
The best understood model of nuclear export proposes that a protein or protein-
RNA complex containing an NES associates with an export receptor such CRMI or 
CAS 1. Both CRM 1 and CAS 1 have been shown to be distantly related to the importin 
f3 protein. CRM-l binds, cooperatively with the Ran GTPase (Fomerod et al., 1997), to 
the NES of the protein being exported to the cytoplasm, and the entire complex then exits 
the nucleus through the nuclear pore (Gerace, 1., 1995; 1995; Fomerod et aI., Cell, 1997; 
Stade et al., 1997; Fomerod et al., EMBO, 1997; Kudo et ai., 1998; Kudo et al., 1997). 
The protein then dissociates from the Ran, also with the aid of GTP hydrolysis 
(F omerod et al., 1997). 
The putative NES for CRM 1 mediated transport has been shown to be a sequence 
of 10-12 amino acids rich in leucine (xLxxLxxLxLx) (Fomerod et al., 1997). This sequence 
has been shown to directly associate with CRM -1 and has been found in proteins like 
Rev and PKI (Fomerod et aI., Cell, 1997; Fukuda et al., 1997; Stade et al., 1997). The 
function of nuclear export appears to be dependent on the function of the protein 
containing the NES sequence, but a theme is developing in which nuclear export functions 
to deliver active nuclear transcription factors to the cytoplasm for degradation. Examples 
of this type of mechanism include the p53 protein where function is controlled in part 
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through nuclear export and subsequent degradation by cytoplasmic proteases (Freedman 
and Levine, 1999; Tao and Levine, 1999; Tao and Levine, 1999), and the cyclin dependent 
kinase, p27Kipl (Sherr, C.l., 1996). The common theme in both pathways is that the export 
of the affector protein from the nucleus results in reduced levels of gene regulation since 
the protein is being removed from its site of action. 
Recently it has been clearly established that the AHR protein is rapidly degraded 
both in vivo and in vitro subsequent to agonist binding (Pollenz, R.S., 1996; Giannone et 
al., 1998; Giannone et ai., 1995; Pollenz et al., 1998; Roman et al., 1998; Sommer et aI., 
1998). It has also been shown that the AHR contains a putative NES sequence 
(Davarinos and Pollenz, 1999; Ikuta et aI., 1999; Pollenz and Barbour, 2000). Thus, 
studies have been performed to establish the relationship between the nuclear export of 
the AHR and protein degradation. The studies have shown that blockage of AHR 
degradation through inhibition of the 26S proteasome results in i) increased levels of AHR 
in the nucleus, ii) increased levels of AHRIARNT complexes associated with DNA, and 
iii) increased levels of gene induction following exposure to 2,3,7,8 tetrachlorodibenzo-p-
dioxin (Davarinos and Pollenz, 1999). In addition, studies have shown that when nuclear 
export of the AHR is blocked by the fungal antibiotic leptomycin B (LMB), the AHR is 
accumulated within the nucleus following ligand binding and is not degraded efficiently 
(Davarinos and Pollenz, 1999). Taken together, these findings support the hypothesis 
that nuclear export is required for the ligand bound AHR to be degraded and this type of 
biological mechanism is consistent with the mechanism involved in the degradation of p53 
and P27Kipl. 
86 
The purpose of the studies detailed in this thesis was to further evaluate the 
function of nuclear export and import of the AHR with focus on the relationship between 
nuclear export and AHR-mediated gene regulation. The studies show that it is possible to 
generate AHR proteins with mutations in the NES that dimerizes with ARNT, binds 
DNA and supports ligand-mediated gene induction. However, the studies also 
demonstrate that treatment of cells with LMB results in inhibition of AHR-mediated gene 
regulation even though high levels of AHRI ARNT complex are bound to DNA. Thus, the 
results indicate that there is a clear relationship between nuclear export and AHR-
mediated gene regulation, but that the relationship is complex and involves mechanisms 
that are directly and indirectly related to the AHR protein. The experiments with NLS 
mutants showed that these mutants retained functionality at the level of DNA binding, 
and thus were likely to be capable of inducing gene expression. Additionally, the NLS 
mutants were degraded more slowly after agonist exposure than wtAHR suggesting 
another level of regulation of the AHR pathway. 
II. SPECIFIC AIMS 
The purpose of the studies detailed in this thesis was to generate plasmids that 
encoded AHR mutant genes that could be used to study the behavior and significance of 
the following aspects of the AHR pathway: 1) nuclear export of AHR protein, 2) nuclear 
import of AHR protein, and 3) real time movement of AHR between the nucleus and the 
cytoplasm. To accomplish these goals the specific aims listed below were established for 
this study. 
1. Create a plasmid that encodes mutant AHR protein deficient in nuclear 
export but unimpaired in ability to dimerize with ARNT and induce gene expression by 
binding to the XRE. 
2. Create a plasmid that encodes mutant AHR protein deficient in nuclear 
import but unimpaired in ability to dimerize with ARNT and induce gene expression by 
binding to the XRE. 
3. Create a plasmid that encodes an AHR-GFP protein but unimpaired in 
ability to dimerize with ARNT and induce gene expression by binding to the XRE. 
III. MATERIALS AND METHODS 
Chemicals 
TeDD (98% stated chemical purity) was obtained from the Radian Corp. (Austin, TX) 
and was solubilized in dimethyl sulfoxide (DMSO). 
Buffers 
Phosphate-buffered saline (PBS) is 0.8% NaCI, 0.02% KCI, 0.14% Na2HP04, 0.02% 
K2HP04, pH 7.4. 
Sample buffer is 125 mM Tris, pH 6.8,4% SDS, 25% glycerol, 4 mM EDTA, 20 mM 
dithiothreitol, 0.005% bromphenol blue. 
Tris-buffered saline is 50 mM Tris, 150 mM NaCI, pH 7.5 
Tris-buffered saline with Tween 20 is 50 mM Tris, 0.20/0 Tween 20, 150 mM NaCI, 
pH 7.5. 
Tris-buffered saline with Tween 20+ is 50 mM Tris, 0.5% Tween 20, 300 mM NaCI, 
pH 7.5. 
BLOTTO is 5% dry milk in Tris-buffered saline with Tween 20. 
Gel shift buffer (5X) is 50 mM Hepes, pH 7.5, 15 mM MgCI2, 500/0 glycerol. 
Tris borate-EDTA is 45 mM Tris borate, 1 mM EDTA. 
Antibodies -- All antibodies are affinity-purified IgG fractions. For Western blot analysis 
goat anti-rabbit antibodies conjugated to horseradish peroxidase (GAR-HRP) were 
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utilized .. This reagent was purchased from Jackson Immunoresearch (West Grove, PA). 
Polyclonal rabbit -actin antibodies were purchased from Sigma. 
Quantitative Western Blot Analysis of AHR and ARNT-Protein samples were resolved by 
SDS-PAGE and electrophoretically transferred to nitrocellulose. Immunochemical 
staining was carried out by primary antibody in BLOTTO. Normally blots were washed 
three times in TTBS+ for a total of 45 minutes. The blot was then incubated for one hour 
in BLOTTO with GAR-HRP and washed with TTBS+ as previously described. ECL 
exposures were scanned into a Power Macintosh computer utilizing an HP Scanjet II cm 
with Adobe Photoshop ™ software. Images were quantified utilizing NIH image 1.55 
software. The raw level of AHR protein was then divided by the level of ~-actin protein 
to generate normalized values for the concentration of the AHR in each sample 
Electrophoretic Mobility Shift Assay-A double-stranded XRE fragment corresponding to 
the consensus XRE-l of the CYPIAI promoter was labeled with [a-32P]dCTP by 
Klenow. Approximately 10-20 ~g of nuclear extract were then incubated at 22°C for 15 
min in gel shift buffer supplemented with KCI (80 mM) and poly( dI-dC) (0.1 mg/ml). 
Approximately 4 ng of 32P-Iabeled XRE were then added to each sample, and the 
incubation was continued for an additional 15 min at 22°C. The samples were resolved 
on 5% acrylamide, 0.5% Tris borate-EDTA gels, dried, and exposed to film. 
In Vitro Mutagenesis -Site-directed mutagenesis All mutagenesis for this project was 
performed with this Stratagene QwikChange ™ kit. Mutagenic primers (25-45 bases long) 
were designed as complementary pairs so that a primer would anneal to each strand on 
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the template. The desired mutation was situated in the center of the prImers. The 
prImers were synthesized by MUSC's Biotechnology Resource Laboratory. The 
lyophilized primers were resuspended in 1 ml 20 mM Tris-HCI, pH 7.5. In thin-walled 
PCR tubes, IX reaction buffer (10 mM KCI, 6 mM (NH4)2S04, 20 mM Tris-HCI, pH 8, 
2 mM MgCh, 0.1 % Triton® X-I00, 10 mg/ml nuclease-free BSA), 100 ng plasmid 
template, 125 ng mutagenic primers, and 0.20 mM dNTPs were mixed and diluted to a 
final volume of 50 J.lI with distilled water. To each mutagenesis reaction, 2.5 units (U) of 
Pfu DNA polymerase was added for the amplification of the plasmid. The samples were 
then placed in a thennocycler for the PCR. 
After mutagenesis, the parental plasmids were digested for 1-2 hours at 37°C with 
10 or 20 U of Dpn I restriction enzyme. Dpn I digests only methylated DNA. The 
template DNA was extracted from E. coli cells and methylated by the cells natural 
methylation enzymes. The mutagenized plasmids are PCR amplified copies of the 
template and, therefore unmethylated. After Dpn I digest the uncut plasmid was 
transformed into XLI-Blue supercompetent cells. 
IV. RESULTS 
AHR has been shown to possess putative export and import signals, and as 
previously discussed recent experiments have shown that AHR is degraded by the 26S 
proteasome (Davarinos and Pollenz, 1999: Ma et a/., 2000). This degradation has 
also shown to be inhibited when nuclear export is blocked by the fungal antibiotic LMB 
(Davarinos and Pollenz, 1999). The experiments detailed in this thesis were performed 
in order to gain greater insight into the role or lack thereof for nuclear import andlor 
export in the degradation of AHR subsequent to ligand exposure. 
Although data from earlier experiments had shown that LMB blocked nuclear 
export, and thus, inhibited degradation, there remained the possibility that degradation 
was blocked by some means other than the prevention of AHR export to the cytoplasm. 
Since LMB is a general inhibitor of nuclear export, and LMB is an exogenous substance 
with potentially unknown effects on cellular metabolism the following hypotheses 
remained to be tested. 1) Is degradation of AHR inhibited by LMB because the transport 
of a protein other than AHR itself was blocked? 2) Is degradation of AHR inhibited 
through some action of LMB exerted directly on the 26S proteasome degradation 
pathway? To investigate these possibilities the following procedures were performed. 
A. NES Mutants 
1. Creation of NES Mutants 
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Site-directed mutagenesis of the AHR NES was used to generate mutants that 
were deficient in the ability to be exported from the nucleus, thus eliminating the need to 
use LMB to block nuclear export. The putative NES of the AHR is a leucine rich 
sequence (LDKLSVLRL) located between amino acid 63-71 in the proximal region of the 
helix number 2 of the helix-loop-helix domain (Gerace, 1995; Ikuta et aI., 1998; Davarinos 
and Pollenz, 1999). Microinjection experiments with proteins containing residues 55-75 
of AHR fused to green florescent protein (GFP) have shown that this sequence is 
sufficient to target the fusion protein for export to the cytoplasm (Ikuta et aI., 1998). 
Additionally in these experiments it was shown that fusion proteins with mutations 
leucine to alanine at residues 69 and 71 of the AHR sequence were no longer able to target 
the fusion protein for export from the nucleus. Based on these reports it was decided to 
mutate the NES for experiments with full length AHR. 
Because of the multiple and overlapping functions of AHR protein there were additional 
factors to be considered other than the ability of the AHR mutants to be exported. The 
helix-loop-helix region which encompasses the AHR NES is also involved in dimerization 
of bHLH/P AS proteins (Fukunaga et al., 1995). Therefore, it was necessary insure that a 
mutation made to inhibit nuclear export, did not also inhibit the protein's ability to form 
dimers with its co-activator protein, ARNT. To avoid this problem, the helix-loop-helix 
domains of several ARNT binding bHLH/P AS proteins were compared to define which 
residues were most highly conserved and therefore, less likely to be good candidates for 
mutation. Sequence alignment showed that 5 of the 9 amino acids of the AHR NES were 
conserved between hypoxia factor 1 a, (HIF -1 a), the single-minded protein (SIM), and 
HELIX 1 I I LOOP I HELIX 2 
H1F ESEVFYELAHQL PLPHNVSS HLDKASVMRLTISYLRVRKLLDAG -
ENSEFYELAKLL PLPSAITS QVDKASII RLTTSYLKMRVVFPEG - S1M 
ENLEFFELAKLL PLPGAISI QLDKASIVRLSVTYLRLRR - NPAS 
LNTELDRLASLL PFPQDVIN KLDKLSVLRLSVTYLRAKSFFDVA - AHR 
AHR NES 




Figure 17: Sequence Comparison of Helix 2 of Basic Helix-Loop-HelixIPAS 
Proteins: Comparison of the helix 2 region of for bHLH/PAS proteins, HIF-la, SIM, 
NP AS, and AHR show that 5 residues corresponding to those found in the AHR NBS are 
100% conserved in the four proteins. Additionally the first leucine is conserved in 3 of 
the four proteins. The second leucine of the AHR NES is not found in any of the other 
proteins but is actually conserved in the other three proteins as an alanine residue. The 
third leucine is not conserved in any of the compared sequences. Leucine number four is 
conserved in all four proteins. Based on this information Leucines two and three were 
chosen for mutations as it seemed likely that these residues would be less likely to affect 
AHR dimerization with ARNT. The ARNT sequence is shown below for comparison 
with that of its dimerization partners. 
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the nuclear PAS protein (NPAS). Since these proteins have not been shown to undergo 
nuclear export it seemed likely that the conserved residues could be important for protein 
dimerization (Figure 3). Importantly, only the leucine residues that bracketed the AHR 
NES (positions 63 and 71) were conserved among all the proteins while leucine 66 was an 
alanine in the other sequences and the residues that aligned to leucine 69 were valine, 
isoleucine or methionine. Therefore, leucine 66 and 69 were deemed less important for 
dimerization activity and were selected for mutation. 
Based on the infonnation from the comparison of other bHLH/P AS proteins and 
the reported results from the AHR NES-GFP fusion studies, four AHR NES mutants 
were generated by site-directed mutagenesis. These mutations were: 1) AHR6,NES, 2) 
AHR A66, 3) AHRA69 , 4) AHRAM,. AHR6.NES contains leucine to alanine substitutions at 
amino acids 69 and 71 (Figure 4). These mutations are identical to those in the AHR 
NES-GFP fusion proteins which were shown to be retained in the nucleus (Ikuta et aI., 
1998). Although this mutation had been shown to be effective in inhibiting nuclear export 
in the fusion proteins, comparison of the NES regions of other bHLH/P AS proteins 
showed leucine 71 to be conserved in each of the proteins compared. This infonnation 
suggested that it was likely that this mutant could be deficient in its ability to dimerize 
with ARNT. AHRA66 contains a leucine to alanine substitution at amino acid 66. In the 
three other bHLH/P AS proteins compared in Figure 3 this residue was an alanine, thus it 
seemed likely that this mutation would not interfere with the ability to dimerize with 
ARNT. AHRA69 contains a leucine to alanine substitution at amino acid 69. Alanine was 
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Figure 18: Comparison of NES Mutants With Wild Type AHR: Mutant AHR NES 
sequences are compared to the wild type AHR NES and the consensus NES sequence. 
AHRA66 mutates the second leucine residue to alanine. AHRA69 mutates leucine number 
three also to alanine. AHRAM is a double mutant with the second leucine changed to 
alanine and the third leucine changed to a methionine. This mimics the sequence found in 
the dimerization domain of the bHLHIP AS protein HIF -1 <l. AHRt1NES is also a double 
mutant with leucines three and four changed to alanines. 
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chosen as the mutation for this residue because this was one of the residues that was 
mutated in AHR NES-GFP fusion protein which deficient in nuclear export. Also 
comparisons with other bHLH/P AS proteins did not indicate a preferred residue at this 
position. AHRAM contains a leucine to alanine substitution at amino acid 66 and a 
leucine to methionine substitution at amino acid 69. These amino acid changes were made 
so that AHRAM showed 100% identity to the HIF-la protein from amino acids 64-71. It 
seemed highly unlikely that a mutant with a this sequence would fail to dimerize with 
ARNT, since HIF-la itself dimerizes with ARNT. 
2. Characterization of NES Mutants 
After generation of plasmids expressing AHR proteins with mutated NESs the 
functional abilities of the new AHR proteins were examined. To compare dimerization 
and DNA binding functions of the four NES mutants with that of wild type AHR 
(wtAHR), AHRA66, AHRA69, AHRAM, AHR~NES, and wtAHR proteins were expressed in 
vitro and quantified by Western blotting. In vitro assays were performed first to 
determine which mutant AHRs would be most suitable for in vivo studies, and to study 
the function of these proteins without the added variable of nuclear export. Equal 
amounts of each AHR protein were mixed with equal amounts of ARNT protein and the 
sample was incubated in the presence of TCDD or DMSO for 2 hours at 30°C. After 
incubation a [32p]dCTP labeled double stranded XRE probe was added to each mix and 
then the new mixtures were incubated for an additional 15 minutes. The formation of 
AHRIARNT-XRE complexes was then evaluated by electrophoretic mobility shift assay 
(EMSA) (Figure 4). Each of the AHR NES mutants exhibited some level ofTCDD-
dependent binding to the XRE when compared to the wtAHR protein. However, the 
ability to bind the XRE varied greatly between the AHR mutants. AHR~NEs, as was 
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suggested by the comparison of bHLH/P AS sequences, showed the least ability to bind 
the XRE at only 18% of the level of wtAHR. AHRA66 and AHRMA each bound only to 
approximately 50% of the level ofwtAHR. These results were somewhat unexpected 
since the residues corresponding to leucine 66 of AHR were already alanines in the other 
bHLH/P AS proteins, and as previously discussed, the leucine 71 to methionine mutation 
also mimicked the sequence ofHIF-la. Finally, the AHRA69 protein appeared to 
function at about the same level as the wtAHR in the context of the in vitro EMSA 
assay. This result was not unexpected since the comparison ofbHLH/PAS sequences had 
shown a different residue at this position for each protein. Immunoprecipitation 
experiments indicated that the variation in the levels of DNA binding observed in the 
EMSA could be explained by the variations in the levels of dimerization of the different 
AHR proteins. These results show that the AHRA69 protein exhibits TCDD-dependent 
function at the level ofwtAHR in dimerization and DNA binding in vitro. However, 
substitutions at residues 66 or 71 appear to negatively affect AHR function in 
dimerization and DNA binding in vitro. That these results were obtained in vitro 
suggests they are independent of any nuclear export function of the proteins. The ability 
of AHRA69 to function at wild type levels indicated that it was the mutant best suited for 
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Figure 19: EMSA of wild type AHR and AHR mutants: The EMSA shown below 
illustrates the comparative binding abilities of the AHR mutant proteins with that of wild 
type AHR. Densitometry was performed to calculate the relative number of 
AHRI ARNT /XRE complexes formed by each protein. The results are graphically 
illustrated below. AHRA66 and ARRAM formed complexes at a level approximately 50% 
that of wtARR. AHRA69 levels were similar to those of wtAHR and AHR~NES fonned 
complexes at only 18% that of wtAHR. 
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protein. Therefore, AHRA69 was chosen to be used in microinjection experiments to 
detennine if the mutant protein was deficient in nuclear export, and in experiments with 
cultured cells to examine the effects of inhibition of nuclear export in vivo. 
B. NLS Mutants 
1. Creation of NLS Mutants 
As previously discussed, in the absence of ligand, AHR is generally found in the 
cytoplasm in an inactive multiprotein complex that minimally consists of the AHR 
protein itself along with two molecules of hsp90 (Perdew, 1988; Pollenz et aI., 1994: 
Holmes and Pollenz, 1997). Other experiments have also indicated the presence of an 
additional 37-43 kDa protein associated with this complex (Chen and Perdew, 1994), and 
also, a 330 amino acid protein with sequence similarity to a 52 kDa immunophilin co-
activator of the glucocorticoid receptor, has been shown to be associated with ligand 
activated AHR (Carver and Bradfield, 1997; Ma and Whitlock, 1997). Upon exposure to 
ligand, AHR complex is translocated to the nucleus where the AHR can dimerize with 
ARNT and induce gene expression by binding to the XRE or be transported back out into 
the cytoplasm where it is degraded. 
AHR is targeted for translocation to the nucleus by a nuclear localization signal 
(NLS). The minimal NLS sequence for AHR has been identified as sequence of 27 amino 
acid residues, numbering 13-39 in the protein sequence (Ikuta et ai., 1998). This 27 
residue sequence is described as a bipartite NLS with basic amino acid residues clustered 
at both the 5' and 3' ends of the signal (see Figure 5). In vitro experiments with fusion 
proteins containing the AHR NLS have shown that mutations in anyone of the residues 
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AHR NLS Sequence Comparison 
RKRRKPVQKTVKPIPAEGIKSNPSKRH WT 
QKRRKPVQKTVKPIPAEGIKSNPSKRH NLS-l 
QPRRKPVQKTVKPIPAEGIKSNPSKRH - NLS-2 
Figure 20: Nuclear Localization Signal Sequence Comparison of wtAHR and NLS 
Mutants: The AHR NLS is a bipartate NLS signal consisting of two regions rich in basic 
residues separated by a spacer sequence. The basic regions of the NLS are shown in red 
and the three red underlined bases at the N-tenninal end of the sequence are required for 
the sequence to retain any ability to target the protein to the nucleus. The residues 
shown in green are the mutated residues of the two mutants. The basic region involved in 
DNA binding is underlined in black. 
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13-15 is sufficient to completely knock out the ability of this sequence to target proteins 
to the nucleus (Ikuta et al., 1998). 
Although experiments with the previously described AHR NES mutants had 
shown that blocking nuclear export of AHR also inhibits its degradation, it was still not 
known if both nuclear import and export were necessary for degradation to occur. 
Although degradation had been shown to occur in the cytoplasm it was not yet known if 
agonist exposure and localization of AHR to the cytoplasm was sufficient to target AHR 
for degradation. There remained the possibility that an event occurring in the nucleus 
after import was necessary to make AHR competent for degradation. Vectors expressing 
AHR proteins with mutated NLSs were constructed to test this hypothesis. 
Qwikchange ™ site-directed mutagenesis was used to generate the vectors encoding AHR 
proteins with mutated NLSs. 
As was necessary when generating the NES mutants, multiple functions of parts 
of the NLS sequence had to be considered when deciding which residues could be mutated 
without affecting the functionality of the protein in ways other than nuclear localization. 
The basic region consists of residues 27-39 and is therefore completely overlapped by the 
NLS signal previously discussed (Burbach et al., 1992; Fukunaga et al., 1995). This 
region is responsible for the DNA-binding ability of the AHR (Fukunaga et al., 1995) and 
mutations made in this region could block the ability of AHR to bind the XRE and induce 
gene expression. This possibility should have no bearing on the initial experiment to 
determine if degradation is inhibited if the AHR is not transported to the nucleus, because 
the NLS mutants are designed not to be transported into the nucleus and therefore cannot 
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dimerize with ARNT or bind to the XRE. However, additional experiments such as 
microinjection of the NLS mutant proteins as controls would require a completely 
functional protein except for the ability to be imported to the nucleus. Fortunately, the 
previously discussed mutations in residues 13-15, which had previously been shown to 
completely block nuclear localization of a fusion protein were outside of the DNA 
binding region of AHR. However, in those experiments the NLS sequences were part of a 
fusion protein and therefore, were never examined for the ability to bind DNA. 
Based on this information two AHR mutants with defective NLSs were generated. 
One mutant contained the single residue change mutation, RI3Q, and the other contained 
two residue changes, RI3Q:KI4P. The single and double NLS mutations were designated 
AHRNLS1 and AHRNLS2 respectively. Although a single mutation in bases 13-15 had been 
shown to completely knock out nuclear localization in a fusion protein, the double 
mutation was made to give added assurance that the NLS was disrupted for experiments 
with the full length AHR protein. 
2. Characterization of the NLS Mutants 
Functionality of the two NLS mutants was then compared with that of wtAHR. 
AHRNLS1 , AHRNLS2, and wtAHR proteins were expressed in vitro and quantified by 
Western blotting. Equal amounts of each AHR were then mixed with equal amounts of 
ARNT protein and the sample was incubated in the presence of TCDD or DMSO for 2 
hours at 30°C. After incubation a [32p]dCTP labeled double stranded XRE probe was 
added to each mix and then the new mixtures were incubated for an additional 15 minutes. 
The fonnation of AHRI ARNT complexes was then evaluated by EMSA (Figure 7). Both 
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EMSA of AHR NLS Mutants 
AHR NLS-1 NLS-2 
+ + + 
AHR NLS-1 NLS-2 TCDD TCDD TCDD 
Figure 21:EMSA of AHR NLS Mutants: The functionality of AHR NLS mutants was 
compared to that of wtAHR by EMSA. Both NLS mutants retained the ability to form 
dimers with ARNT and bind to DNA in vitro. 
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Figure 22: AHRlGFP Fusion Proteins: Efforts to generate AHRlGFP fusion proteins 
were began with wtAHR and the four NES mutants. The fusion proteins were to be used 
to observe the movement and degradation of AHR in real time rather than by means of 
western blots and stained cells. To this time efforts to generate the fusion proteins have 
been unsuccessful. 
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transfected genes even if both are visualized by the AHR antibodies. Additionally the 
presence of GFP would allow visualization with antibodies to the GFP protein so the 
only protein visualized would be the transformant. Potentially the greatest benefit of this 
approach would be the ability to follow in real time the import, export and degradation of 
the AHRlGFP fusion. This would be possible because the GFP can be visualized under a 
microscope without fixing and killing the cells. The NES mutants and wtAHR were to be 
made first and if successful the same approach could be used with other AHR proteins 
(Figure 8). 
A three-part procedure was required to generate the AHRlGFP fusion proteins. 
First the stop codon for the AHR gene would be replaced by a restriction site which 
could be cut to open or linearize the plasmid and allow the insertion of the OFP sequence. 
QwikchangeTM mutagenesis was used to replace the stop codon with the BssH II 
restriction site. BssH II was chosen because this procedure requires a single cut 
restriction site and because the OFP sequence and the pSport plasmid already contained 
sites for many of the readily available restriction enzymes. Plasmids containing a BssH II 
site and each of the AHR proteins except AHRA69 were generated using this method. 
Numerous attempts have been made to make a plasmid with AHRA69 and the BssH II site 
but as yet none were successful. Second the GFP sequence was amplified from the 
plasmid pEYFP-Nuc by polymerase chain reaction (peR). Primers were used which 
generated a peR product with BssH II sites at both ends of the OFP sequence. Finally 
both the pSportAHR vectors and the OFP peR product were digested with BssH II and 
then ligated with T4 ligase. XLI-Blue supercompetent cells were transformed with the 
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ligase mix then plated for overnight growth. This third and final step necessary to 
generate plasmids expressing AHRlGFP fusion proteins has been attempted a number of 
times but as yet none have been successful. This project is unfinished at this time. 
DISCUSSION 
The work presented in this thesis was performed to set the stage for molecular 
analysis of both the NLS and NES of the AHR protein, and as yet does not tell a 
complete story. The production of the NES and NLS vectors were to form a basis from 
which future research could be carried out on the AHR pathway. Indeed, these vectors 
have already been used to address some of the important questions. The NES vectors 
described within this thesis were used to show that blocking nuclear export of AHR 
inhibits the degradation of the AHR protein (Davarinos and Pollenz, 1999; Pollenz and 
Barbour, 2000). These results demonstrate that the export of the AHR is required for 
degradation of AHR, thus answering the initial question posed for this work (Pollenz and 
Barbour, 2000). 
Since the export of AHR from the nucleus results in degradation of the AHR and 
therefore greatly reduced levels of total AHR protein in the cell, it is likely that export 
and degradation are important steps in regulating AHR mediated gene induction. 
Degradation of the AHR protein is likely a mechanism to terminate or reduce the 
induction signal and attenuate the cellular response to the stimulant. In recent 
experiments, the effects of blocking the export of AHR on gene induction have been 
examined. Results of these experiments indicate that gene induction is increased when 
AHR export and subsequent degradation is inhibited (Pollenz and Barbour, 2000). 
110 
To this point experiment with cells expressing the AHR NES mutant proteins 
have been conducted in transiently transfected cells. Transient transfections result in 
uneven expression of the genes being studied in the individual cells, with some cells highly 
overexpressing and others with little or no expression. This uneven expression can 
produce results that are inconsistent and therefore difficult to understand. Stable cell 
lines are currently being generated which express these plasmids and it is expected that 
results of studies using these cells will allow more rigorous analysis of export and AHR 
signaling. 
Recent experiments with the NLS mutants described here have suggested that 
translocation of AHR to the nucleus may play some role in targeting the protein for 
subsequent degradation (Pollenz, unpublished data). In these experiments AHR proteins 
with the mutant NLS sequences described in this thesis have been shown to be localized 
to the cytoplasm even after exposure to TCDD. Evidence from western blots of lysates 
from cells expressing AHR with mutant NLS sequences have also indicated that 
degradation of the import defective AHR proteins occurs at a slower rate than does that 
of wtAHR. These experiments have also been conducted in transiently transfected cells 
and for future experiments stable cell lines are being generated. 
Other future plan include the eventual creation of "knock-in" mIce expressIng 
AHR genes with both deficient NES and NLS sequences. The availability of these 
mutations in mice will allow the examination of differences in phenotypes, if any, of mice 
with the different import and export signals. Of particular interest will be the effects of 
potentiation expression of genes induced by the AHR pathway, which is expected to 
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occur in these animals, since they will lack the ability to rapidly export and degrade AHR, 
thus attenuating the response to agonist. These changes in phenotype should yield 
valuable information concerning the role AHR localization in the growth and development 
of the transfected animals. 
Although efforts to generate plasmids which express AHRlGFP fusion proteins 
were unsuccessful, this work will continue. If this project is successfully implemented it 
should be possible to observe in real time the import, export, and degradation of AHR, 
and therefore obtain much more detailed and accurate information about the AHR 
mediated pathway. 
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